JP6219928B2 - 農業用作物保護剤の製造方法 - Google Patents
農業用作物保護剤の製造方法 Download PDFInfo
- Publication number
- JP6219928B2 JP6219928B2 JP2015506901A JP2015506901A JP6219928B2 JP 6219928 B2 JP6219928 B2 JP 6219928B2 JP 2015506901 A JP2015506901 A JP 2015506901A JP 2015506901 A JP2015506901 A JP 2015506901A JP 6219928 B2 JP6219928 B2 JP 6219928B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- nmr
- methyl
- plant
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000011814 protection agent Substances 0.000 title claims description 48
- 238000004519 manufacturing process Methods 0.000 title claims description 22
- 241000196324 Embryophyta Species 0.000 claims description 143
- 150000001875 compounds Chemical class 0.000 claims description 141
- -1 1-methoxycarbonyl-2-phenylethylcarbamoyl Chemical group 0.000 claims description 91
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 91
- 239000007788 liquid Substances 0.000 claims description 65
- 108010016626 Dipeptides Proteins 0.000 claims description 47
- 201000010099 disease Diseases 0.000 claims description 44
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 44
- 230000000694 effects Effects 0.000 claims description 30
- 150000003839 salts Chemical class 0.000 claims description 26
- 235000002566 Capsicum Nutrition 0.000 claims description 25
- 239000004480 active ingredient Substances 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 18
- 240000008067 Cucumis sativus Species 0.000 claims description 17
- 244000061176 Nicotiana tabacum Species 0.000 claims description 16
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 230000012010 growth Effects 0.000 claims description 14
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 13
- 230000001737 promoting effect Effects 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 12
- 230000008635 plant growth Effects 0.000 claims description 12
- 239000004563 wettable powder Substances 0.000 claims description 12
- 241000607479 Yersinia pestis Species 0.000 claims description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
- 230000036039 immunity Effects 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 9
- 206010035148 Plague Diseases 0.000 claims description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 9
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 claims description 8
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 claims description 8
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 claims description 8
- 230000002708 enhancing effect Effects 0.000 claims description 8
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 7
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 7
- 244000061456 Solanum tuberosum Species 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 6
- 240000003768 Solanum lycopersicum Species 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 238000007667 floating Methods 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- OHSQCRJKGHTLHL-UHFFFAOYSA-N 3-acetamido-4-[(1-methoxy-1-oxo-3-phenylpropan-2-yl)amino]-4-oxobutanoic acid Chemical compound OC(=O)CC(NC(C)=O)C(=O)NC(C(=O)OC)CC1=CC=CC=C1 OHSQCRJKGHTLHL-UHFFFAOYSA-N 0.000 claims description 4
- 241000234282 Allium Species 0.000 claims description 4
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 4
- 240000006108 Allium ampeloprasum Species 0.000 claims description 4
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 4
- 240000002234 Allium sativum Species 0.000 claims description 4
- 244000144730 Amygdalus persica Species 0.000 claims description 4
- 244000105624 Arachis hypogaea Species 0.000 claims description 4
- 240000007124 Brassica oleracea Species 0.000 claims description 4
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 4
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 4
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 4
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 claims description 4
- 244000000626 Daucus carota Species 0.000 claims description 4
- 235000002767 Daucus carota Nutrition 0.000 claims description 4
- 235000011430 Malus pumila Nutrition 0.000 claims description 4
- 235000015103 Malus silvestris Nutrition 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 241000286209 Phasianidae Species 0.000 claims description 4
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 4
- 240000001987 Pyrus communis Species 0.000 claims description 4
- 235000014443 Pyrus communis Nutrition 0.000 claims description 4
- 244000088415 Raphanus sativus Species 0.000 claims description 4
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 4
- 240000003829 Sorghum propinquum Species 0.000 claims description 4
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 4
- 244000273928 Zingiber officinale Species 0.000 claims description 4
- GPTOBIGYULSHLG-UHFFFAOYSA-N benzyl 3-amino-4-[(1-methoxy-1-oxo-3-phenylpropan-2-yl)amino]-4-oxobutanoate Chemical compound C=1C=CC=CC=1COC(=O)CC(N)C(=O)NC(C(=O)OC)CC1=CC=CC=C1 GPTOBIGYULSHLG-UHFFFAOYSA-N 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 235000004611 garlic Nutrition 0.000 claims description 4
- 235000008397 ginger Nutrition 0.000 claims description 4
- 235000020232 peanut Nutrition 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 244000061520 Angelica archangelica Species 0.000 claims description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims description 3
- 235000009849 Cucumis sativus Nutrition 0.000 claims description 3
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 3
- 240000009088 Fragaria x ananassa Species 0.000 claims description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 244000070406 Malus silvestris Species 0.000 claims description 3
- IAOZJIPTCAWIRG-UHFFFAOYSA-N Methyl alpha-aspartylphenylalaninate Chemical compound OC(=O)CC(N)C(=O)NC(C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-UHFFFAOYSA-N 0.000 claims description 3
- 235000004347 Perilla Nutrition 0.000 claims description 3
- 244000124853 Perilla frutescens Species 0.000 claims description 3
- 244000305267 Quercus macrolepis Species 0.000 claims description 3
- CCKAUXJBOBDHLB-UHFFFAOYSA-N methyl 3-amino-4-[(1-methoxy-1-oxo-3-phenylpropan-2-yl)amino]-4-oxobutanoate Chemical compound COC(=O)CC(N)C(=O)NC(C(=O)OC)CC1=CC=CC=C1 CCKAUXJBOBDHLB-UHFFFAOYSA-N 0.000 claims description 3
- 240000008384 Capsicum annuum var. annuum Species 0.000 claims description 2
- 241000219112 Cucumis Species 0.000 claims description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 2
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 2
- 240000008415 Lactuca sativa Species 0.000 claims description 2
- 241000758706 Piperaceae Species 0.000 claims description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 2
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 244000241235 Citrullus lanatus Species 0.000 claims 1
- 241000223218 Fusarium Species 0.000 claims 1
- 241000918585 Pythium aphanidermatum Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 235000012015 potatoes Nutrition 0.000 claims 1
- 239000002023 wood Substances 0.000 claims 1
- 238000005481 NMR spectroscopy Methods 0.000 description 202
- 239000007787 solid Substances 0.000 description 49
- 240000003889 Piper guineense Species 0.000 description 27
- 239000006002 Pepper Substances 0.000 description 20
- 235000016761 Piper aduncum Nutrition 0.000 description 20
- 235000017804 Piper guineense Nutrition 0.000 description 20
- 235000008184 Piper nigrum Nutrition 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 20
- 208000035240 Disease Resistance Diseases 0.000 description 16
- 230000003902 lesion Effects 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 15
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 14
- 230000002401 inhibitory effect Effects 0.000 description 14
- 241000233866 Fungi Species 0.000 description 13
- 230000002595 cold damage Effects 0.000 description 12
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 12
- 241000233616 Phytophthora capsici Species 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 125000000217 alkyl group Chemical group 0.000 description 10
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 238000001308 synthesis method Methods 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 7
- 101000742121 Arabidopsis thaliana Pathogenesis-related protein 1 Proteins 0.000 description 7
- 101000742139 Cucumis melo Pathogenesis-related protein Proteins 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 6
- 229960004889 salicylic acid Drugs 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- QXOGPTXQGKQSJT-UHFFFAOYSA-N 1-amino-4-[4-(3,4-dimethylphenyl)sulfanylanilino]-9,10-dioxoanthracene-2-sulfonic acid Chemical compound Cc1ccc(Sc2ccc(Nc3cc(c(N)c4C(=O)c5ccccc5C(=O)c34)S(O)(=O)=O)cc2)cc1C QXOGPTXQGKQSJT-UHFFFAOYSA-N 0.000 description 5
- 101100063004 Arabidopsis thaliana PDF1.2A gene Proteins 0.000 description 5
- 102000012286 Chitinases Human genes 0.000 description 5
- 108010022172 Chitinases Proteins 0.000 description 5
- 102000003992 Peroxidases Human genes 0.000 description 5
- 101100084161 Phaseolus vulgaris PR4 gene Proteins 0.000 description 5
- 101000900567 Pisum sativum Disease resistance response protein Pi49 Proteins 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000019439 ethyl acetate Nutrition 0.000 description 4
- 239000000417 fungicide Substances 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000007721 medicinal effect Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 3
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 3
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 description 3
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 3
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- 241000193738 Bacillus anthracis Species 0.000 description 3
- 240000008574 Capsicum frutescens Species 0.000 description 3
- 241000219109 Citrullus Species 0.000 description 3
- 102100029952 Double-strand-break repair protein rad21 homolog Human genes 0.000 description 3
- 101000584942 Homo sapiens Double-strand-break repair protein rad21 homolog Proteins 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 101000763602 Manilkara zapota Thaumatin-like protein 1 Proteins 0.000 description 3
- 101000763586 Manilkara zapota Thaumatin-like protein 1a Proteins 0.000 description 3
- 101100464974 Medicago truncatula PR-1 gene Proteins 0.000 description 3
- 101000966653 Musa acuminata Glucan endo-1,3-beta-glucosidase Proteins 0.000 description 3
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 3
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 3
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 241000588701 Pectobacterium carotovorum Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000001390 capsicum minimum Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 230000000361 pesticidal effect Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 2
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 2
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 2
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000222235 Colletotrichum orbiculare Species 0.000 description 2
- 229940127007 Compound 39 Drugs 0.000 description 2
- 241000219104 Cucurbitaceae Species 0.000 description 2
- 241000221785 Erysiphales Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 241000531155 Pectobacterium Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000008122 artificial sweetener Substances 0.000 description 2
- 235000021311 artificial sweeteners Nutrition 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000004067 bulking agent Substances 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 229940125961 compound 24 Drugs 0.000 description 2
- 229940125851 compound 27 Drugs 0.000 description 2
- 229940125807 compound 37 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 229940127113 compound 57 Drugs 0.000 description 2
- 229940125900 compound 59 Drugs 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000007799 cork Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 230000008260 defense mechanism Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 101150054900 gus gene Proteins 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- ZBELDPMWYXDLNY-UHFFFAOYSA-N methyl 9-(4-bromo-2-fluoroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Br)C=C1F ZBELDPMWYXDLNY-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 230000003032 phytopathogenic effect Effects 0.000 description 2
- BXRNXXXXHLBUKK-UHFFFAOYSA-N piperazine-2,5-dione Chemical compound O=C1CNC(=O)CN1 BXRNXXXXHLBUKK-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-M prolinate Chemical compound [O-]C(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-M 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
- FNHHVPPSBFQMEL-KQHDFZBMSA-N (3S)-5-N-[(1S,5R)-3-hydroxy-6-bicyclo[3.1.0]hexanyl]-7-N,3-dimethyl-3-phenyl-2H-1-benzofuran-5,7-dicarboxamide Chemical compound CNC(=O)c1cc(cc2c1OC[C@@]2(C)c1ccccc1)C(=O)NC1[C@H]2CC(O)C[C@@H]12 FNHHVPPSBFQMEL-KQHDFZBMSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 1
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 description 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 1
- OMBVEVHRIQULKW-DNQXCXABSA-M (3r,5r)-7-[3-(4-fluorophenyl)-8-oxo-7-phenyl-1-propan-2-yl-5,6-dihydro-4h-pyrrolo[2,3-c]azepin-2-yl]-3,5-dihydroxyheptanoate Chemical compound O=C1C=2N(C(C)C)C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C(C=3C=CC(F)=CC=3)C=2CCCN1C1=CC=CC=C1 OMBVEVHRIQULKW-DNQXCXABSA-M 0.000 description 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 1
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 description 1
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 1
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 1
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 1
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 1
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 description 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 1
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- WFOVEDJTASPCIR-UHFFFAOYSA-N 3-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)methylamino]-n-[[2-(trifluoromethyl)phenyl]methyl]benzamide Chemical compound N=1N=C(C=2C=CN=CC=2)N(C)C=1CNC(C=1)=CC=CC=1C(=O)NCC1=CC=CC=C1C(F)(F)F WFOVEDJTASPCIR-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000003974 3-carbamimidamidopropyl group Chemical group C(N)(=N)NCCC* 0.000 description 1
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 1
- MPMKMQHJHDHPBE-RUZDIDTESA-N 4-[[(2r)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid Chemical compound O=C([C@@]1(N(CC1)C(=O)C=1C2=CC=CC=C2SC=1)C)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1 MPMKMQHJHDHPBE-RUZDIDTESA-N 0.000 description 1
- 125000003143 4-hydroxybenzyl group Chemical group [H]C([*])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 description 1
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 1
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 description 1
- XASOHFCUIQARJT-UHFFFAOYSA-N 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one Chemical compound C(N1C(=O)C2=C(OC)C=C(C=3N4C(=NC=3)C=C(C=C4)OCCN3CCOCC3)C=C2CC1)C(F)(F)F XASOHFCUIQARJT-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241001480061 Blumeria graminis Species 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 1
- ISMDILRWKSYCOD-GNKBHMEESA-N C(C1=CC=CC=C1)[C@@H]1NC(OCCCCCCCCCCCNC([C@@H](NC(C[C@@H]1O)=O)C(C)C)=O)=O Chemical compound C(C1=CC=CC=C1)[C@@H]1NC(OCCCCCCCCCCCNC([C@@H](NC(C[C@@H]1O)=O)C(C)C)=O)=O ISMDILRWKSYCOD-GNKBHMEESA-N 0.000 description 1
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 1
- BQXUPNKLZNSUMC-YUQWMIPFSA-N CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 Chemical compound CCN(CCCCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](C)c1ccc(cc1)-c1scnc1C)C(C)(C)C)CCOc1ccc(cc1)C(=O)c1c(sc2cc(O)ccc12)-c1ccc(O)cc1 BQXUPNKLZNSUMC-YUQWMIPFSA-N 0.000 description 1
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 1
- 101100256918 Caenorhabditis elegans sid-2 gene Proteins 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 235000001250 Cardamine diphylla Nutrition 0.000 description 1
- 244000250392 Cardamine diphylla Species 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 229940126639 Compound 33 Drugs 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 101150031726 ERS1 gene Proteins 0.000 description 1
- 101150115493 FAD3 gene Proteins 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 101000732336 Homo sapiens Transcription factor AP-2 gamma Proteins 0.000 description 1
- 101000868549 Homo sapiens Voltage-dependent calcium channel gamma-like subunit Proteins 0.000 description 1
- 101000802094 Homo sapiens mRNA decay activator protein ZFP36L1 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 244000081841 Malus domestica Species 0.000 description 1
- 101000726683 Metarhizium anisopliae Cuticle-degrading protease Proteins 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 101100204733 Schizosaccharomyces pombe (strain 972 / ATCC 24843) gus1 gene Proteins 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 101000611441 Solanum lycopersicum Pathogenesis-related leaf protein 6 Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 208000002564 X-linked cardiac valvular dysplasia Diseases 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 229940008309 acetone / ethanol Drugs 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical group CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 229940125878 compound 36 Drugs 0.000 description 1
- 229940127573 compound 38 Drugs 0.000 description 1
- 229940126540 compound 41 Drugs 0.000 description 1
- 229940125936 compound 42 Drugs 0.000 description 1
- 229940125844 compound 46 Drugs 0.000 description 1
- 229940127271 compound 49 Drugs 0.000 description 1
- 229940126545 compound 53 Drugs 0.000 description 1
- 229940126179 compound 72 Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 description 1
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 125000006302 indol-3-yl methyl group Chemical group [H]N1C([H])=C(C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])* 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 102100034702 mRNA decay activator protein ZFP36L1 Human genes 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004372 methylthioethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])* 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- ACTNHJDHMQSOGL-UHFFFAOYSA-N n',n'-dibenzylethane-1,2-diamine Chemical compound C=1C=CC=CC=1CN(CCN)CC1=CC=CC=C1 ACTNHJDHMQSOGL-UHFFFAOYSA-N 0.000 description 1
- YCJZWBZJSYLMPB-UHFFFAOYSA-N n-(2-chloropyrimidin-4-yl)-2,5-dimethyl-1-phenylimidazole-4-carboxamide Chemical compound CC=1N(C=2C=CC=CC=2)C(C)=NC=1C(=O)NC1=CC=NC(Cl)=N1 YCJZWBZJSYLMPB-UHFFFAOYSA-N 0.000 description 1
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229910052903 pyrophyllite Inorganic materials 0.000 description 1
- NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- NZSZYROZOXUFSG-UHFFFAOYSA-N tert-butyl n-(1-amino-3-methyl-1-oxobutan-2-yl)carbamate Chemical compound CC(C)C(C(N)=O)NC(=O)OC(C)(C)C NZSZYROZOXUFSG-UHFFFAOYSA-N 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N33/02—Amines; Quaternary ammonium compounds
- A01N33/08—Amines; Quaternary ammonium compounds containing oxygen or sulfur
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
- A01N41/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom not containing sulfur-to-oxygen bonds, e.g. polysulfides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
- A01N43/38—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/12—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof containing a —O—CO—N< group, or a thio analogue thereof, neither directly attached to a ring nor the nitrogen atom being a member of a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
- C07K5/06069—Ser-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
- C07K5/06121—Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cultivation Of Plants (AREA)
Description
前記ジペプチド誘導体は、
メチル2−(2−アミノ−4−メチルペンタンアミド)アセテート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−メチルブタンアミド)アセテート;
メチル2−(2−アミノ−3−メチルブタンアミド)アセテート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−ヒドロキシブタンアミド)−4−メチルペンタノエート;
メチル2−(2−アミノ−3−ヒドロキシブタンアミド)−4−メチルペンタノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−エタンアミド)プロパノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−((4−ヒドロキシフェニル)プロパンアミド)プロパノエート;
エチル2−(2−((t−ブトキシカルボニル)アミノ)−3−メチルペンタンアミド)−プロパノエート;
3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパン酸;
メチル3−(1−メトキシカルボニル−2−フェニルエチルカルバモイル)−3−(t−ブトキシカルボニルアミノ)プロパノエート;
メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ブトキシカルボニルアミノ)プロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパノエート;
メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパノエート;
メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ベンゾイルアミノ)プロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ベンゾルアミノ)プロパノエート;
3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパン酸;
メチル2−((2−アセチルアミノ)−3−メチルブタンアミド)アセテート;
メチル2−((2−アセチルアミノ)−4−メチルペンタンアミド)アセテート;
メチル2−(2−アミノ−3−メチルペンタンアミド)プロパノエート、又は農薬学的に許容可能なそれらの塩から選択された化合物を活性成分として含むことを特徴とする農業用作物保護剤の製造方法である。
また、本発明は上記製造方法であって、前記農業用作物保護剤は、水和剤、懸濁剤、乳濁剤、液剤、分散性液剤、顆粒水和剤、粒剤、粉剤、液状水和剤、顆粒水和剤、水面浮上性粒剤、または錠剤に構成されたグループから選択された種類から形成された製造方法である。
また、本発明は、前記農業用作物保護剤は、植物病防除効能、植物生長促進効能、植物免疫増強効能、またはこれらの効能を同時に有することを特徴とする製造方法である。
また、本発明は、前記農業用作物保護剤が前記植物病防除効能を有する植物病は、軟腐病、立枯病、疫病、つる割病、斑点病、またはモザイク病であることを特徴とする製造方法である。
また、本発明は、前記植物は、双子葉植物であることを特徴とする製造方法である。
また、本発明は、前記双子葉植物は、ジャガイモ、トウガラシ、ピーマン、トマト、キュウリ、タバコ、スイカ、マクワウリ、ハクサイ、チシャ、大根、キャベツ、アブラナ、ピーナッツ、サラリー、ニンジン、トウキ、エゴマ、イチゴ、リンゴの木、梨の木、桃の木及び柿の木からなる群から選択されることを特徴とする製造方法である。
また、本発明は、前記植物は、ネギ、ニンニク、ショウガ、タマネギ、稲、麦、トウモロコシ、モロコシ、であることを特徴とする製造方法である。
また、ネギ、ニンニク、ショウガ、タマネギ等の植物や、稲、麦、トウモロコシ、モロコシ等の禾本科植物に適用されて優れた薬効を示す。
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−ヒドロキシプロパンアミド)−4−メチルペンタノエート;
メチル2−(2−アミノ−3−ヒドロキシプロパンアミド)−4−メチルペンタノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−4−メチルペンタンアミド)アセテート;
メチル2−(2−アミノ−4−メチルペンタンアミド)アセテート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−メチルブタンアミド)アセテート;
メチル2−(2−アミノ−3−メチルブタンアミド)アセテート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−ヒドロキシブタンアミド)−4−メチルペンタノエート;
メチル2−(2−アミノ−3−ヒドロキシブタンアミド)−4−メチルペンタノエート;
エチル2−(2−((t−ブトキシカルボニル)アミノ)−4−メチルペンタンアミド)プロパノエート;
エチル2−(2−アミノ−4−メチルペンタンアミド)プロパノエート;
2−(2−アミノ−4−メチルペンタンアミド)プロパン酸;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−メチルブタンアミド)プロパノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−プロパンアミド)プロパノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−エタンアミド)プロパノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−((4−ヒドロキシフェニル)プロパンアミド)プロパノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−アセトプロパンアミド)−3−(インドール−3−イル)プロパノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−メチルブタンアミド)−3−(インドール−3−イル)プロパノエート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−フェニルプロパノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)プロパノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−メチルブタノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−4−メチルペンタノイル)ピロリジン−2−カルボキシレート;
メチル1−(5−アミノ−2−((t−ブトキシカルボニル)アミノ)−5−ヨードペンタノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−ヒドロキシブタノイル)ピロリジン−2−カルボキシレート;
メチル1−(4−t−ブトキシ−2−((t−ブトキシカルボニル)アミノ)−4−ヨードブタノイル)ピロリジン−2−カルボキシレート;
メチル1−(4−アミノ−2−((t−ブトキシカルボニル)アミノ)−4−ヨードブタノイル)ピロリジン−2−カルボキシレート;
t−ブチル2−((2−メトキシカルボニル)ピロリジン−1−カルボニル)ピロリジン−1−カルボキシレート;
メチル1−((2,6−ビス(t−ブトキシカルボニル)アミノ)ヘキサノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−(イミダゾール−4−イル)プロパノイル)ピロリジン−2−カルボキシレート;
メチル1−(5−t−ブトキシ−2−((t−ブトキシカルボニル)アミノ)−5−ヨードペンタノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−(4−ヒドロキシフェニル)プロパノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−メチルペンタノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)アセチル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−ヒドロキシプロパノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−4−メチルチオブタノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−(インドール−3−イル)プロパノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−トリチルチオプロパノイル)ピロリジン−2−カルボキシレート;
メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−メルカプトプロパノイル)ピロリジン−2−カルボキシレート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−4−メチルペンタンアミド)−3−ヒドロキシブタノエート;
エチル2−(2−((t−ブトキシカルボニル)アミノ)−3−メチルペンタンアミド)−プロパノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−ヒドロキシプロパンアミド)−アセテート;
エチル2−(2−((t−ブトキシカルボニル)アミノ)−エタンアミド)−プロパノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−4−メチルペンタンアミド)−3−フェニルプロパノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−エタンアミド)−3−メチルブタノエート;
メチル2−(2−アミノ−エタンアミド)−3−メチルブタノエート;
3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパン酸;
メチル3−(1−メトキシカルボニル−2−フェニルエチルカルバモイル)−3−(t−ブトキシカルボニルアミノ)プロパノエート;
メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパノエート;
アリル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ブトキシカルボニルアミノ)プロパノエート;
アリル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ブトキシカルボニルアミノ)プロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパノエート;
メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパノエート;
メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ベンゾイルアミノ)プロパノエート;
アリル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパノエート;
アリル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ベンゾイルアミノ)プロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ベンゾイルアミノ)プロパノエート;
3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパン酸;
メチル2−((2−アセチルアミノ)−3−メチルブタンアミド)アセテート;
メチル2−((2−アセチルアミノ)−4−メチルペンタンアミド)アセテート;
メチル2−((2−ピロリジンカルバモイル)アミノ)アセテート;
メチル1−(2−アミノ−3−(インドール−3−イル)プロパノイル)ピロリジン−2−カルボキシレート;
メチル2−(2−アミノ−3−メチルブタンアミド)プロパノエート;
メチル2−(2−アミノ−3−メチルペンタンアミド)プロパノエート;及び農薬学的に許容可能なその塩から選択された化合物である。
より限定的には、メチル2−(2−アミノ−4−メチルペンタンアミド)アセテート;メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−メチルブタンアミド)アセテート;メチル2−(2−アミノ−3−メチルブタンアミド)アセテート;メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−ヒドロキシブタンアミド)−4−メチルペンタノエート;メチル2−(2−アミノ−3−ヒドロキシブタンアミド)−4−メチルペンタノエート;メチル2−(2−((t−ブトキシカルボニル)アミノ)−エタンアミド)プロパノエート;メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−((4−ヒドロキシフェニル)プロパンアミド)プロパノエート;メチル1−(2−((t−ブトキシカルボニル)アミノ)−3−トリチルチオプロパノイル)ピロリジン−2−カルボキシレート;エチル2−(2−((t−ブトキシカルボニル)アミノ)−3−メチルペンタンアミド)−プロパノエート;3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパン酸;メチル3−(1−メトキシカルボニル−2−フェニルエチルカルバモイル)−3−(t−ブトキシカルボニルアミノ)プロパノエート;メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパノエート; アリル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ブトキシカルボニルアミノ)プロパノエート;アリル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパノエート;ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ブトキシカルボニルアミノ)プロパノエート;ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパノエート;メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパノエート;メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ベンゾイルアミノ)プロパノエート;アリル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパノエート;アリル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ベンゾイルアミノ)プロパノエート;ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパノエート;ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ベンゾルアミノ)プロパノエート;3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパン酸;メチル2−((2−アセチルアミノ)−3−メチルブタンアミド)アセテート;メチル2−((2−アセチルアミノ)−4−メチルペンタンアミド)アセテート;メチル2−(2−アミノ−3−メチルペンタンアミド)プロパノエートが挙げられる。
R 2 は、水素原子を表し、
R 3 及びR 4 は、同一であるか異なるものであって、水素原子、または、C 1 〜C 18 の直鎖または分岐鎖のアルキル基であり、ヒドロキシ、カルボン酸、C 1 〜C 18 の直鎖または分岐鎖のアルコキシカルボニル、ベンジルオキシカルボニル、トリチルチオ、フェニル又は、ヒドロキシフェニルからなる群から選択された基で置換されたC 1 〜C 18 の直鎖または分岐鎖のアルキル基と、または置換されていないC 1 〜C 18 の直鎖または分岐鎖のアルキル基とを含み、
R 5 は、水素原子を表し、
R 6 及びR 7 は、同一であるか異なるものであって、水素原子、または、C 1 〜C 18 の直鎖または分岐鎖のアルキル基であり、ヒドロキシ、フェニルからなる群から選択した基で置換されたC 1 〜C 18 の直鎖または分岐鎖のアルキル基と、置換されていないC 1 〜C 18 の直鎖または分岐鎖のアルキル基とを表し、
R 8 は、C 1 〜C 18 の直鎖または分岐鎖のアルコキシ基を表す。
本発明に用いる前記ジペプチド誘導体は、2,5−ジケトピペラジン化合物を合成するための中間体であって、これらの製法は既に様々な文献に公知されている[非特許文献4ないし9]。したがって、有機合成分野に属する通常の技術者ならば、公知文献などにより本発明に用いるジペプチド誘導体を容易に合成することができる。
一方、本発明に用いる前記ジペプチド誘導体または農薬学的に許容可能なその塩は、植物から抵抗性遺伝子を発現させて植物病抵抗性蛋白質の生産を誘導することにより、細菌、ウイルス、かび菌により誘発される各種植物病に抵抗する効能を示すので、農業用作物保護剤の活性成分として有効である。前記細菌、ウイルス、かび菌により誘発される各種植物病は、具体的には、植物の軟腐病、立枯病、疫病、つる割病、斑点病、モザイク病などである。
また、ネギ、ニンニク、ショウガ、タマネギ等の植物や、稲、麦、トウモロコシ、モロコシ等の禾本科植物に適用される。
代表合成例.ジペプチド誘導体の合成
(1)ジペプチド合成法A(化合物1、3、5、7、9、12〜24、26、27、29、32〜36、38〜47、49、51〜60、62〜73、75、76、79〜87、106)
様々なL型またはD型のN−Boc−アミノ酸(3.0mmol)をジメチルホルムアミド(DMF)10mLに入れて溶かした。これにジイソプロピルエチルアミン(DIEA;0.78g、6.0mmol)、O−(ベンゾトリアゾール−1−イル)−N,N,N,N−テトラメチルウロニウムヘキサフルオロリン酸塩(HBTU;1.37g、3.6mmol)を入れ、30分間撹拌した。この反応混合物にL型またはD型のアミノ酸アルキル(メチルまたはエチル)エステル(塩酸塩)(3.6mmol)を入れ、常温で12時間撹拌した。反応混合物をエチルアセテートに希釈し、炭酸水素ナトリウム、塩水で洗浄した。有機層を無水硫酸ナトリウムで水を除去し、減圧下で濃縮した。濃縮液をシリカカラムクロマトグラフィー(EtOAc/Hexane)により精製して線形のN−Boc−L−アミノ酸−L−アミノ酸アルキルエステルを得た。前記縮合反応の収率は概ね50%ないし95%である。
システインのSH基がトリチル基で保護されたシステイン、末端COOH基がアルキルエステルに変換されたアスパラギン酸またはグルタミン酸誘導体、リシンとアルジニンの場合には末端アミノ基がBocやベンジルオキシカルボニル基で保護された物質(10.0mmol)を使用して、前記合成法Aと同様な方法により線形のN−Boc−L−アミノ酸−L−アミノ酸アルキルエステルを合成した。前記縮合反応の収率は概ね65%ないし80%である。
合成法AとBで得られたN−Boc−アミノ酸−アミノ酸アルキルエステル(5mmol)を50%トリフルオロ酢酸の塩化メチレン溶液(20mL)に溶かし、2時間撹拌した。減圧下で溶媒を飛ばし、Bocやトリチルのような保護基が除去されたアミノ酸−アミノ酸アルキルエステルトリフルオロ酢酸塩を得た。他の方法には、N−Boc−アミノ酸−アミノ酸メチルエステル(5mmol)をギ酸(10mL)に溶かし、6時間撹拌した後に真空濃縮して保護基が除去されたアミノ酸−アミノ酸アルキルエステルギ酸塩を得た。化合物89は、Sigma−Aldrichで購入して使用し、化合物91、93、95は、前記合成法によって得ることもできるが、化合物89からMeCN/MeOHでそれぞれヨウ化メチル、臭化アリル及び塩化ベンジルと反応させて得ることもできる。
合成法AとBで得られたN−Boc−アミノ酸−アミノ酸アルキルエステルを再び水溶性ジオキサンに溶かし、LiOHを当量ほど入れた後に一晩撹拌した。次いで、酢酸で中和し、アセトン/エタノール混合溶媒で三回抽出してアルキル基が除去されたアミノ酸−アミノ酸を得た。
合成法Cで得られたアミノ酸−アミノ酸アルキルエステル塩(0.57mmol)を塩化メチレン(5mL)に溶かし、塩化アシル(1.2eq)とトリエチルアミン(2.4eq)を入れて室温で2時間撹拌した。この反応混合物を、EtOAc(50mL)を入れた後に1M HCl溶液、炭酸ナトリウム及び飽和塩水で洗浄して濃縮した。濃縮液をシリカカラムクロマトグラフィー(EtOAc/Hexane)により精製して、N−アシルアミノ酸−アミノ酸アルキルエステルを90%以上の収率で得た。
無色液体; 1H NMR(400MHz, CD3OD) δ 4.17(1H, t, J=4Hz), 4.50(1H, dd, J=6.0, 9.0Hz), 3.75(2H, dd, J=11.2, 5.2Hz), 3.70(3H, s), 1.63(1H, m), 1.70-1.62(2H, m), 1.45(9H, br s), 0.93(3H, d, J=6.8Hz), 0.92(3H, d, J=6.8Hz).
化合物2
無色液体; 1H NMR(400MHz, CD3OD) δ 4.51(1H, m), 4.50(1H, m), 3.87(2H, d, J=11.2, 5.2Hz), 3.70(3H, s), 1.66-1.63(2H, m), 1.62(1H, m), 0.95(3H, d, J=6.4Hz), 0.92(3H, d, J=6.4Hz).
化合物3
白色結晶; 1H NMR(400MHz, CD3OD) δ 4.12(1H, m), 3.97(1H, d, J=17.6Hz), 3.88(1H, d, J=17.6Hz), 3.70(3H, s), 1.71(2H, m), 1.53(1H, m), 1.44(9H, br s), 0.95(3H, d, J=6.8Hz), 0.93(3H, d, J=6.8Hz); 13C NMR(100MHz, CD3OD) δ 174.9, 170.1, 156.4, 79.1, 52.9, 51.1, 40.8, 40.4, 27.2, 24.4, 22.0, 20.4.
化合物4
1H NMR(400MHz, CD3OD) δ 4.07(2H, d, J=17.6Hz), 3.90(1H, m), 3.72(3H, s), 1.63(1H, m), 1.60-1.70(2H, m), 0.93(3H, d, J=6.4Hz), 0.90(3H, d, J=6.4Hz).
化合物5
白色固体; 1H NMR(400MHz, CD3OD) δ 0.93(3H, d, J=6.8Hz), 0.97(3H, d, J=7.2Hz), 1.44(9H, br s), 2.06(1H, m), 3.67(3H, s), 3.91(1H, m), 3.97(2H, m); 13C NMR(100MHz, CD3OD) δ 173.6, 170.0, 156.5, 79.1, 59.9, 51.1, 40.3, 30.6, 27.2, 18.2, 16.8.
化合物6
白色固体; 1H NMR(400MHz, CD3OD) δ 1.06(3H, d, J=2.8Hz), 1.08(3H, d, J=2.8Hz), 2.20(1H, m), 3.71(3H, s), 3.74(1H, d, J=5.6Hz), 3.93(1H, d, J=17.6Hz), 4.09(1H, d, J=17.6Hz); 13C NMR(100MHz, CD3OD) δ 171.5, 170.3, 59.8, 52.8, 41.9, 31.6, 18.7, 18.0.
化合物7
無色液体; 1H NMR(400MHz, CD3OD) δ 4.50(1H, dd, J=6.0, 5.6Hz), 4.05(1H, m), 4.00(1H, m), 3.69(3H, s), 1.70(1H, m), 1.68(1H, m), 1.60(1H, m), 1.44(9H, br s), 1.19(3H, d, J=6.4Hz), 0.94(3H, d, J=6.4Hz), 0.91(3H, d, J=6.4Hz); 3C NMR(100MHz, CD3OD) δ 173.0, 172.0, 156.5, 79.3, 67.1, 59.9, 51.2, 50.6, 40.1, 27.2, 24.3, 21.8, 20.4, 18.6.
化合物8
白色固体; 1H NMR(400MHz, CD3OD) δ 4.47(1H, dd, J=6.0, 6.0Hz), 4.35(1H, d, J=6Hz), 4.10(1H, q. J=6Hz), 3.70(3H, s), 1.70(1H, m), 1.68(1H, m), 1.60(1H, m), 1.21(3H, d, J=6.4Hz), 0.95(3H, d, J=6.8Hz), 0.90(3H, d, J=6.8Hz).
化合物9
白色固体; 1H NMR(400MHz, CD3OD) δ 4.38(1H, q, J=7.6Hz), 4.16(2H, q, J=7.2Hz), 4.11(1H, t, J=4.4Hz), 1.73(2H, m), 1.52(1H, m), 1.43(9H, br s), 1.38(3H, d, J=7.2Hz), 1.25(3H, t, J=7.2Hz), 0.95(3H, d, J=6.8Hz), 0.93(3H, d, J=6.8Hz).
化合物10
白色固体; 1H NMR(400MHz, CD3OD) δ 4.38(1H, q, J=7.0Hz), 4.16(2H, q, J=7.2Hz), 3.36(1H, t, J=6.4Hz), 1.73(2H, m), 1.52(1H, m), 1.38(3H, d, J=7.2Hz), 1.25(3H, t, J=7.2Hz), 0.96(3H, d, J=6.4Hz), 0.93(3H, d, J=6.4Hz); 13C NMR(100MHz, CD3OD) δ 176.3, 172.6, 160.8, 52.7, 48.2, 44.2, 24.2, 21.8, 21.2, 16.0, 13.0.
化合物11
白色固体; 1H NMR(400MHz, CD3OD) δ 1.84(1H, m), 1.61(1H, dd, J=8.4, 5.6Hz), 1.64(1H, dd, J=8.4, 5.2Hz), 3.93(1H, ddd, J=8.4, 4.4, 0.8Hz), 3.99(1H, ddd, J=14.0, 6.8, 0.8Hz), 1.44(3H, d, J=6.8Hz), 0.96(3H, t, J=6.8Hz), 0.96(3H, t, J=6.8Hz).
化合物12
白色固体; 1H NMR(CDCl3, 400MHz) δ 8.10(1H, s), 7.96(1H, s), 4.60(1H, q), 4.52(1H, d), 3.67(3H, s), 2.66(1H, m), 1.48(3H, s), 1.40(9H, s), 1.01(6H, d); 13C NMR(CDCl3, 100MHz) δ 171.6, 171.1, 156.0, 79.5, 60.3, 51.9, 48.2, 31.0, 28.5, 17.1.
化合物13
白色固体; 1H NMR(CDCl3, 400MHz) δ 6.68(1H, s), 5.12(1H, s), 4.59-4.53(1H, m), 4.17(1H, s), 3.73(3H, s), 1.43(9H, s), 1.37-1.31(6H, m); 13C NMR(CDCl3, 100MHz) δ 173.1, 172.3, 155.4, 80.0, 52.4, 49.9, 47.9, 28.2, 18.3, 18.2.
化合物14
粘性液体; 1H NMR(400MHz, CDCl3): δ 6.50(1H, s), 6.22(1H, s), 4.74-4.69(1H, m), 3.59(3H, s), 3.49-3.47(2H, d), 1.54(9H, s), 1.29-1.27(3H, d); 13C NMR(CDCl3, 100MHz) δ 171.6, 170.7, 156.3, 79.5, 51.9, 47.9, 45.0, 28.5, 17.2.
化合物15
粘性液体; 1H NMR(400MHz, CDCl3) δ 7.02(2H, d), 6.74(2H, d), 6.55(1H, d), 5.11(1H, s), 4.52(1H, t), 4.29(1H, s), 3.70(3H, s), 2.97(2H, dd), 1.41(9H, s), 1.33(3H, d); 13C NMR(CDCl3,100MHz) δ 171.6, 170.7, 156.3, 79.5, 51.9, 47.9, 45.0, 28.5, 17.2.
化合物16
白色固体; 1H NMR(CDCl3, 400MHz) δ 8.34(1H, s), 7.50(1H, d), 7.34(1H, d), 7.19(1H, t), 7.12(1H, t), 6.97(1H, d), 6.63(1H, d), 5.11(1H, m), 4.93(1H, m), 3.73(2H, s), 3.66(3H, s), 3.31(2H, d), 1.41(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.1, 169.1, 156.2, 136.1, 127.5, 123.0, 122.2, 119.6, 118.3, 111.3, 109.6, 80.2, 52.8, 52.4, 44.2, 38.6, 28.2, 27.5.
化合物17
白色固体; 1H NMR(DMSO-d6, 400MHz) δ 8.95(1H, s), 7.50-7.48(1H, d), 7.16-7.02(4H, m), 6.72(1H, s), 6.02(1H, s), 4.88-4.84(1H, m), 4.28-4.23(1H, m), 3.54(3H, s), 3.25-3.23(2H, d), 1.55(9H, s), 1.52-1.47(1H, m), 1.01-0.99(6H, d); 13C NMR(DMSO-d6, 400MHz) δ 175.8, 171.2, 152.5, 135.9, 128.5, 122.8, 120.7, 119.6, 118.1, 112.2, 109.3, 79.9, 55.6, 51.9, 37.8, 28.7(3C), 26.6, 24.2(2C), 21.4.
化合物18
粘性液体; 1H NMR(CDCl3, 400MHz) δ 7.2(1H, s), 5.29(1H, s), 4.45(2H, d), 3.85(2H, d), 3.67(3H, s), 1.45(9H, s); 13C NMR(CDCl3, 100MHz) δ 171.5, 171.0, 155.5, 80.3, 51.2, 48.5, 46.1, 29.0.
化合物19
1H NMR(CDCl3, 400MHz) δ 7.31-7.20(5H, m), 5.24(1H, d), 4.67(1H, dd), 4.50(1H, dd), 3.74(3H, s), 3.61-3.57(1H, m), 3.19-3.15(1H, m), 3.11(1H, dd), 2.93(1H, dd), 2.17-2.13(1H, m), 1.96-1.88(3H, m), 1.37(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.5, 170.8, 155.3, 136.5, 129.9, 128.5, 126.9, 79.8, 60.6, 59.1, 53.4, 52.4, 47.0, 39.4, 29.2, 28.5, 25.0.
化合物20
粘性液体; 1H NMR(CD3OD, 400MHz) δ 4.46(1H, dd, J=4.8, 8.8Hz), 4.37(1H, q, J=6.8Hz), 3.77(1H, m), 3.69(3H, s), 3.65-3.62(1H, m), 3.60-3.54(1H, m), 2.30-2.23(1H, m), 2.07-1.93(3H, m), 1.42(9H, s), 1.28(3H, d, J=7.6Hz); 13C NMR(CDCl3, 100MHz) δ 172.7, 172.6, 156.2, 79.0, 58.9, 51.3, 47.7, 46.6, 28.5, 27.3, 24.5, 15.7.
化合物21
1H NMR(CDCl3, 400MHz) δ 5.19(1H, d), 4.52(1H, dd), 4.28(1H, dd), 3.77-3.73(1H, m), 3.70(3H, s), 3.64-3.62(1H, m), 3.59-3.56(1H, m), 2.23-2.19(1H, m), 2.03-1.94(3H, m), 1.40(9H, s), 1.02(3H, d), 0.92(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.6, 171.4, 156.0, 79.6, 58.9, 57.0, 52.3, 47.3, 31.5, 29.2, 28.5, 25.2, 19.4, 17.5.
化合物22
1H NMR(CDCl3, 400MHz) δ 5.09(1H, d), 4.45(1H, dd), 4.39(1H, dd), 3.71-3.68(1H, m), 3.62(3H, s), 3.53-3.51(1H, m), 2.16-2.11(1H, m), 2.01-1.86(3H, m), 1.72-1.65(1H. m), 1.42(1H, t), 1.33(9H, s), 0.92(3H, d), 0.87(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.6, 171.9, 155.8, 79.5, 58.8, 52.3, 50.4, 46.8, 42.0, 29.1, 28.4, 25.0, 24.6, 23.5, 21.9.
化合物23
白色固体; 1H NMR(CDCl3, 400MHz) δ 6.50(1H, s), 5.95(1H, s), 5.57(1H, d), 4.47-4.42(2H, m), 3.66-3.63(2H, t), 3.64(3H, s), 2.27-2.22(2H, m), 2.16-2.04(2H, m), 1.97-1.89(3H, m), 1.81-1.77(1H, m), 1.35(9H, s); 13C NMR(CDCl3, 100MHz) δ 175.1, 172.5, 170.6, 155.8, 79.7, 58.7, 52.2, 50.9, 46.9, 31.2, 29.0, 28.9, 28.3, 28.2, 24.9.
化合物24
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.48(1H, d), 4.50(1H, dd), 4.38(1H, dd), 4.14(1H, m), 3.76-3.74(1H, m), 3.69(3H, s), 3.47(1H, s), 2.22-2.20(1H, m), 2.01-1.93(3H, m), 1.40(9H, s), 1.19(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.5, 170.9, 156.1, 79.9, 67.4, 58.8, 55.7, 52.7, 52.4, 47.2, 38.5, 31.3, 28.9, 24.8, 18.5.
化合物25
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.32(1H, d), 4.81(1H, dd), 4.46(1H, dd), 3.73-3.69(2H, m), 3.67(3H, s), 2.65(1H, dd), 2.45(1H, dd), 2.17-2.12(1H, m), 2.01-1.90(3H, m), 1.39(9H, s), 1.35(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.4, 172.2, 170.0, 155.0, 80.9, 79.7, 59.3, 58.8, 53.4, 52.5, 52.1, 49.1, 48.9, 46.8, 46.5, 31.2, 28.9, 27.9, 24.7.
化合物26
粘性液体; 1H NMR(CDCl3, 400MHz) δ 6.85(1H, s), 6.17(1H, d), 6.02(1H, s), 4.78(1H, dd), 4.42(1H, dd), 3.76-3.70(1H, m), 3.61(3H, s), 2.64-2.46(1H, m), 2.17-2.12(1H, m), 2.16-2.04(2H, m), 1.99-1.89(3H, m), 1.34(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.8, 172.4, 171.0, 155.5, 79.7, 59.1, 52.5, 52.2, 49.4, 47.1, 46.6, 37.8, 28.9, 28.3, 24.8.
化合物27
粘性液体; 1H NMR(CDCl3, 400MHz) δ 4.50(1H, dd), 4.43(1H, dd), 3.69(3H, s), 3.57-3.28(4H, m), 2.12-1.73(8H, m), 1.37(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.7, 171.6, 157.7, 79.8, 60.5, 58.7, 51.9, 47.1, 46.0, 29.7, 28.5, 22.6, 22.1.
化合物28
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.30(1H, d), 4.83(1H, s), 4.54(1H, dd), 4.46(1H, dd), 3.72(3H, s), 3.63-3.58(1H, m), 3.13-3.08(2H, m), 2.24-2.18(2H, m), 2.07-1.93(3H, m), 1.76-1.73(1H, m), 1.60-1.37(5H, m), 1.42(18H, s); 13C NMR(CDCl3, 100MHz)δ 172.5, 171.6, 156.0, 155.2, 79.6, 58.7, 52.3, 51.5, 46.9, 32.3, 28.9, 28.4, 28.3, 24.9, 21.9.
化合物29
白色固体; 1H NMR(CDCl3, 400MHz) δ 7.67(1H, s), 7.42(1H, s), 6.90(1H, s), 5.59(1H, d), 4.59(1H, dd), 4.48(1H, dd), 3.71(3H, s), 3.62-3.58(1H, m), 3.27-3.22(1H, m), 3.10-2.97(2H, m), 2.19(1H, dd), 1.98-1.82(3H, m), 1.35(9H, s); 13C NMR(CDCl3, 100MHz) δ 173.4, 170.6, 155.2, 135.2, 127.9, 122.5, 79.9, 59.0, 52.6, 51.9, 47.0, 29.5, 28.9, 28.8, 28.3, 28.2, 25.1.
化合物30
白色固体; 1H NMR(CDCl3, 400MHz) δ 5.34(1H, d), 4.54-4.49(1H, m), 4.39(1H, dd), 3.69(3H, s), 3.66-3.54(2H, m), 2.34-2.18(2H, m), 2.17-1.87(5H, m), 1.76-1.67(1H,m), 1.41(18H, s); 13C NMR(CDCl3, 100MHz) δ 172.3, 172.1, 170.5, 155.5, 80.4, 79.5, 59.2, 52.6, 52.2, 51.3, 51.0, 49.1, 48.9, 46.9, 46.4, 31.4, 30.6, 28.0, 27.8, 24.7.
化合物31
淡黄色固体; 1H NMR(CDCl3, 400MHz) δ 9.38(1H, s), 9.18(1H, s), 7.29-7.16(10H, m), 5.32(1H, d), 5.14(2H, s), 5.03(2H, s), 4.38(1H, dd), 4.34(1H, dd), 3.92(2H, m), 3.56-3.52(1H, m), 3.50(3H, s), 3.42-3.38(1H, m), 2.67(2H, d), 2.06-2.00(1H, m), 1.82-1.74(2H, m), 1.39-1.21(3H, m), 1.31(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.1, 170.8, 165.5, 163.7, 160.5, 160.4, 155.7, 155.7, 155.4, 137.0, 134.8, 128.6, 128.6, 128.3, 127.9, 127.8, 127.8, 127.6, 79.3, 68.7, 66.8, 58.7, 51.9, 51.5, 46.7, 44.3, 38.5, 29.7, 28.8, 28.3, 24.8, 24.5
化合物32
白色固体; 1H NMR(CDCl3, 400MHz) δ 7.57(1H, s), 7.05(2H, d), 6.70(2H, d), 5.30(1H, d), 4.61(1H, dd), 4.49(1H, dd), 3.68(3H, s), 3.61-3.59(1H, m), 3.28-3.26(1H, m), 3.00(1H, dd), 2.82(1H, dd), 2.13-2.09(1H, m), 1.95-1.88(3H, m), 1.35(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.5, 171.2, 155.8, 130.9, 127.1, 115.6, 80.2, 60.6, 59.2, 53.5, 52.4, 47.1, 38.0, 29.1, 28.5, 25.0, 21.2, 14.3.
化合物33
白色固体; 1H NMR(CDCl3, 400MHz) δ 4.44(1H, dd), 4.39(1H, dd), 3.69(3H, s), 3.61-3.33(4H, m), 2.21-1.78(8H, m), 1.43(9H, s); 13C NMR(CDCl3, 100MHz) δ 173.2, 172.6, 153.9, 79.9, 59.5, 58.0, 52.3, 52.0, 47.1, 46.0, 30.0, 29.4, 28.4, 24.5.
化合物34
白色固体; 1H NMR(CDCl3, 400MHz) δ 5.16(1H, d), 4.42(1H, dd), 4.34(1H, dd), 3.90-3.86(1H, m), 3.70(3H, s), 3.57-3.51(1H, m), 2.20-2.17(1H, m), 2.04-1.92(3H, m), 1.71-1.66(1H, m), 1.59-1.53(1H, m), 1.41(9H, s), 1.16-1.10(1H, m), 0.91(3H, d), 0.88(3H, t); 13C NMR(CDCl3, 100MHz) δ 172.3, 171.1, 155.7, 79.4, 59.1, 56.2, 52.3, 52.1, 47.1, 37.9, 31.1, 29.1, 28.3, 24.6, 24.1, 22.3, 15.6, 11.3, 10.9.
化合物35
白色固体; 1H NMR(CDCl3, 400MHz) δ 7.44(1H, s), 7.00(2H, d), 6.72(2H, d), 5.43(1H, d), 4.59(1H, dd), 4.29(1H, dd), 3.68(3H, s), 3.55-3.49(1H, m), 2.93(1H, dd), 2.84(1H, dd), 2.73-2.69(1H, m), 2.13-2.09(1H, m), 1.94-1.78(3H, m), 1.36(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.3, 170.7, 155.66, 130.4, 127.8, 115.4, 80.0, 60.5, 59.4, 58.8, 53.7, 52.6, 46.9, 39.2, 38.6, 31.1, 28.3, 24.4, 21.2.
化合物36
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.20(1H, d), 4.48(1H, dd), 4.38(1H, dd), 3.85-3.80(1H, m), 3.67(3H, s), 3.54-3.43(2H, m), 2.17-2.02(2H, m), 1.98-1.91(2H, m), 1.68-1.65(1H. m), 1.41(1H, t), 1.38(9H, s), 0.94(3H, d), 0.88(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.6, 171.9, 155.8, 79.5, 59.1, 52.3, 50.4, 46.7, 42.0, 29.1, 28.2, 24.6, 24.2, 23.3, 21.9.
化合物37
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.22(1H, d), 4.78(1H, dd), 4.41(1H, dd), 3.80-3.76(1H, m), 3.67(3H, s), 3.66-3.54(1H, m), 2.73-2.67(1H, dd), 2.50(1H, dd), 2.19-2.14(1H, m), 2.05-1.90(3H, m), 1.35(18H, s); 13C NMR(CDCl3, 100MHz) δ 172.3, 169.7, 169.5, 154.9, 80.9, 79.8, 59.1, 59.0, 52.6, 52.0, 49.3, 48.9, 46.9, 46.6, 31.0, 29.0, 28.2, 27.9, 24.8, 22.4.
化合物38
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.39(1H, s), 4.50(1H, dd), 3.94(1H, dd), 3.69(3H, s), 3.59-3.55(1H, m), 3.46-3.40(1H, m), 2.21-2.14(1H, m), 2.10-1.94(4H, m), 1.40(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.8, 167.7, 156.2, 80.0, 58.8, 52.7, 46.2, 43.4, 29.4, 28.7, 25.0.
化合物39
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.66(1H, d), 4.55(1H, dd), 4.46(1H, dd), 4.38(1H, m), 3.81-3.77(1H, m), 3.71(3H, s), 3.67-3.49(2H, m), 3.37(1H, s), 2.26-2.20(1H, m), 2.11-1.99(1H, m), 2.01-1.91(2H, m), 1.40(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.6, 169.7, 155.8, 80.1, 63.8, 59.4, 53.5, 52.8, 52.3, 47.1, 30.8, 29.0, 24.7, 22.4.
化合物40
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.33(1H, d), 4.57(1H, dd), 4.36(1H, dd), 3.79-3.76(1H, m), 3.64(3H, s), 3.55-3.48(1H, m), 2.50-2.42(2H, m), 2.17-2.12(1H, m), 2.01(3H, s), 1.99-1.83(4H, m), 1.80-1.70(1H, m), 1.35(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.3, 170.4, 155.3, 79.7, 59.1, 53.4, 51.0, 46.9, 32.6, 31.1, 30.1, 30.8, 24.6, 22.3, 15.5.
化合物41
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.52(1H, d), 4.80(1H, dd), 4.50(1H, dd), 3.72(3H, s), 3.67-3.62(1H, m), 2.78(2H, t), 2.28-2.20(1H, m), 2.10-1.92(4H, m), 1.81-1.77(1H, m), 1.35(9H, s), 0.86-0.81(1H, m); 13C NMR(CDCl3, 100MHz) δ 172.3, 172.1, 167.3, 154.7, 80.8, 59.3, 53.0, 52.4, 48.8, 47.2, 46.8, 38.6, 29.0, 28.2, 24.7.
化合物42
粘性液体; 1H NMR(CDCl3, 400MHz) δ 7.23-7.15(5H, m), 5.38(1H, d), 4.61(1H, dd), 4.25(1H, dd), 3.66(3H, s), 3.49-3.45(1H, m), 3.02(1H, dd), 2.90(1H, dd), 2.62-2.57(1H, m), 1.92-1.75(3H, m), 1.49-1.43(1H, m), 1.37(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.3, 170.2, 154.9, 136.4, 129.4, 128.3, 126.8, 79.6, 58.6, 53.5, 52.5, 46.7, 40.3, 28.9, 28.3, 24.3, 22.4.
化合物43
白色固体; 1H NMR(CDCl3, 400MHz) δ 8.45(1H, s), 7.58(1H, d), 7.32(1H, d), 7.16(1H, t), 7.09(1H, t), 7.05(1H, d), 5.52(1H, d), 4.70-4.64(1H, m), 4.15(1H, dd), 3.67(3H, s), 3.40-3.34(1H, m), 3.27(1H, dd), 3.15(1H, dd), 2.47-2.41(1H, m), 1.67-1.44(3H, m), 1.44(9H, s), 1.10-1.06(1H, m); 13C NMR(CDCl3, 100MHz) δ 172.5, 170.9, 155.1, 136.0, 127.5, 123.1, 121.8, 119.4, 118.6, 111.1, 110.7, 79.6, 58.9, 53.4, 52.3, 46.6, 31.4, 30.0, 29.7, 28.7, 28.2, 24.1.
化合物44
白色固体; 1H NMR(CDCl3, 400MHz) δ 5.44(1H, d), 4.48(1H, q), 4.45(1H, dd), 3.79-3.74(1H, m), 3.69(3H, s), 3.51-3.44(1H, m), 2.20-2.16(1H, m), 2.14-1.92(3H, m), 1.38(9H, s), 1.30(3H, d); 13C NMR(CDCl3, 100MHz) δ 175.5, 172.9, 155.4, 79.5, 49.5, 46.2, 36.9, 35.8, 29.4, 28.3, 18.5.
化合物45
白色固体; 1H NMR(CDCl3, 400MHz) δ 6.62(1H, s), 5.82(1H, s), 5.69(1H, d), 4.45(1H, dd), 4.40(1H, dd), 3.69(3H, s), 3.59-3.55(1H, m), 2.31-2.16(5H, m), 2.05-1.93(3H, m), 1.79-1.75(1H, m), 1.40(9H, s); 13C NMR(CDCl3, 100MHz) δ 175.4, 172.5, 170.4, 156.1, 80.0, 59.4, 52.3, 51.2, 46.8, 31.5, 29.5, 29.0, 28.2, 24.6, 22.2.
化合物46
白色固体; 1H NMR(CDCl3, 400MHz) δ 7.49(1H, s), 7.42(1H, s), 6.78(1H, s), 5.63(1H, d), 4.68(1H, dd), 4.31(1H, dd), 3.71(3H, s), 3.63-3.49(2H, m), 3.20-3.14(1H, m), 2.95-2.86(1H, m), 2.05-2.01(1H, m), 1.98-1.70(3H, m), 1.34(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.3, 170.8, 155.2, 135.1, 131.1, 119.6, 79.8, 59.3, 53.4, 52.3, 46.9, 30.3, 28.9, 28.2, 24.6, 22.3.
化合物47
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.50(1H, d), 5.10(1H, dd), 4.43(1H, dd), 4.35(1H, dd), 4.15(1H, q), 3.83-3.78(1H, m), 3.69(3H, s), 3.66-3.64(1H, m), 2.20-2.17(1H, m), 2.04-1.92(3H, m), 1.43(9H, s), 1.15(3H, d); 13C NMR(CDCl3,100MHz) δ 172.5, 171.0, 156.1, 80.0, 67.5, 59.0, 55.1, 54.0, 52.7, 52.3, 47.2, 38.6, 30.7, 29.0, 24.8, 18.7.
化合物48
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.33(1H, d), 4.88(1H, s), 4.53(1H, dd), 4.43(1H, dd), 3.70(3H, s), 3.61-3.59(1H, m), 3.11-3.08(2H, m), 2.21-2.14(2H, m), 2.07-1.91(3H, m), 1.76-1.72(1H, m), 1.61-1.38(5H, m), 1.40(18H, s); 13C NMR(CDCl3, 100MHz) δ 172.4, 171.1, 156.0, 155.5, 79.5, 78.8, 58.6, 52.2, 51.5, 46.8, 40.1, 32.2, 29.3, 28.9, 28.4, 28.3, 24.9, 21.9.
化合物49
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.10(1H, d), 4.22(1H, dd), 4.12(1H, dd), 3.72-3.764(1H, m), 3.51(3H, s), 3.41-3.33(1H, m), 2.03-1.72(5H, m), 1.24(9H, s), 0.77(3H, d), 0.72(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.2, 170.7, 155.5, 79.0, 58.7, 56.7, 51.9, 46.9, 31.1, 28.9, 28.1, 24.5, 19.5, 19.4, 17.2.
化合物50
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.23(1H, d), 4.50-4.48(2H, m), 3.72-3.65(2H, m), 3.68(3H, s), 2.38-2.14(3H, m), 2.09-1.88(4H, m), 1.76-1.67(1H, m), 1.42(18H, s); 13C NMR(CDCl3, 100MHz) δ 172.2, 172.1, 170.8, 155.5, 80.4, 79.5, 59.7, 52.1, 50.9, 46.8, 30.7, 28.9, 28.3, 28.0, 27.7, 24.9.
化合物51
白色固体; 1H NMR(CDCl3, 400MHz) δ 5.44(1H, d), 4.48(1H, q), 4.45(1H, dd), 3.79-3.74(1H, m), 3.69(3H, s), 3.50-3.44(1H, m), 2.21-2.16(1H, m), 2.12-1.92(3H, m), 1.38(9H, s), 1.29(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.6, 171.8, 155.2, 79.6, 59.0, 52.5, 47.9, 46.8, 29.0, 28.3, 24.6, 22.4, 18.7.
化合物52
白色固体; 1H NMR(CDCl3, 400MHz) δ 8.68(1H, s), 7.57(1H, d), 7.32(1H, d), 7.15(1H, t), 7.08(1H, t), 7.02(1H, d), 5.54(1H, d), 4.68-4.65(1H, m), 4.14(1H, dd), 3.65(3H, s), 3.38-3.33(1H, m), 3.26-3.21(1H, m), 3.15(1H, dd), 2.46-2.41(1H, m), 1.65-1.51(3H, m), 1.44(9H, s), 1.10-1.06(1H, m); 13C NMR(CDCl3, 100MHz) δ 172.5, 170.9, 155.1, 136.0, 127.5, 123.2, 121.8, 111.2, 79.6, 58.9, 53.4, 52.1, 46.6, 38.6, 30.0, 28.7, 24.1.
化合物53
淡黄色固体; 1H NMR(CDCl3, 400MHz) δ 7.60(1H, s), 6.99(2H, d), 6.72(2H, d), 5.43(1H, d), 4.57(1H, dd), 4.28(1H, dd), 3.66(3H, s), 3.52-3.50(1H, m), 2.93(1H, dd), 2.83(1H, dd), 2.72-2.66(1H, m), 1.96-1.76(3H, m), 1.56-1.48(1H, m), 1.40(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.6, 170.7, 155.6, 130.4, 127.7, 115.4, 80.0, 58.9, 53.4, 52.6, 52.3, 46.9, 39.2, 28.9, 28.2, 24.4, 22.3.
化合物54
白色固体; 1H NMR(CDCl3, 400MHz) δ 6.65(1H, s), 5.63(1H, dd), 5.55(1H, s), 4.49(1H, dd), 4.41(1H, dd), 3.71(3H, s), 3.68-3.55(2H, m), 2.35-2.14(3H, m), 2.10-1.95(4H, m), 1.79-1.71(1H, m), 1.43(9H, s); 13C NMR(CDCl3, 100MHz) δ 175.0, 172.4, 170.2, 156.2, 79.9, 59.1, 52.2, 51.1, 46.7, 31.6, 30.0, 29.1, 28.3, 24.6, 22.2.
化合物55
白色固体; 1H NMR(CDCl3, 400MHz) δ 4.41(1H, dd), 4.35(1H, dd), 3.64(3H, s), 3.59-3.29(4H, m), 2.17-1.74(8H, m), 1.39(9H, s); 13C NMR(CDCl3, 100MHz) δ 173.1, 172.4, 154.4, 79.8, 59.1, 58.0, 52.0, 46.5, 46.4, 31.5, 29.8, 28.9, 28.4, 24.9, 23.2, 22.5.
化合物56
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.20(1H, d), 4.38(1H, dd), 4.29(1H, dd), 3.87-3.81(1H, m), 3.67(3H, s), 3.54-3.48(1H, m), 2.17-1.87(5H, m), 1.39(9H, s), 0.92(3H, d), 0.87(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.4, 170.9, 155.7, 79.3, 58.8, 56.8, 52.3, 47.0, 31.3, 29.1, 28.3, 24.6, 19.6, 17.3.
化合物57
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.20(1H, d), 4.47(1H, dd), 4.37(1H, dd), 3.84-3.81(1H, m), 3.65(3H, s), 3.53-3.44(2H, m), 2.23-2.02(2H, m), 1.98-1.91(2H, m), 1.68-1.62(1H. m), 1.41(1H, t), 1.37(9H, s), 0.94(3H, d), 0.87(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.3, 171.6, 155.4, 79.4, 58.9, 52.3, 52.1, 50.3, 46.7, 42.6, 29.0, 28.2, 24.6, 24.5, 23.4, 22.3, 21.9.
化合物58
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.15(1H, d), 4.40(1H, dd), 4.31(1H, dd), 3.87-3.86(1H, m), 3.67(3H, s), 3.55-3.49(1H, m), 2.20-1.92(4H, m), 1.69-1.64(1H, m), 1.55-1.49(1H, m), 1.39(9H, s), 1.12-1.04(1H, m), 0.89(3H, d), 0.86(3H, t); 13C NMR(CDCl3, 100MHz) δ 172.3, 171.1, 155.7, 79.4, 58.8, 56.2, 52.2, 52.1, 47.1, 37.8, 31.1, 29.1, 28.3, 24.6, 24.0, 15.6, 11.2.
化合物59
粘性液体; 1H NMR(CDCl3, 400MHz) δ 7.22-7.13(5H, m), 5.38(1H, d), 4.62(1H, dd), 4.25(1H, dd), 3.67(3H, s), 3.52-3.46(1H, m), 3.03(1H, dd), 2.91(1H, dd), 2.63-2.59(1H, m), 1.92-1.75(3H, m), 1.49-1.42(1H, m), 1.39(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.3, 170.2, 154.9, 136.4, 129.4, 128.3, 126.5, 79.6, 59.2, 53.6, 52.5, 46.7, 40.3, 28.9, 28.3, 28.2, 24.4.
化合物60
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.65(1H, d), 4.56(1H, dd), 4.46(1H, dd), 3.79-3.52(4H, m), 3.71(3H, s), 3.35(1H, s), 2.27-2.17(1H, m), 2.09-1.93(3H, m), 1.40(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.3, 169.7, 155.8, 80.2, 63.9, 59.4, 53.5, 52.8, 52.3, 47.1, 29.0, 28.2, 24.7, 22.4.
化合物61
白色固体; 1H NMR(CDCl3, 400MHz) δ 7.40(6H, d), 7.28(6H, t), 7.21(3H, t), 5.22(1H, d), 4.44(1H, dd), 4.38(1H, dd), 3.67(3H, s), 3.61-3.56(1H, m), 3.13-3.07(1H, m), 2.59(1H, dd), 2.42-2.34(1H, m), 2.13-1.81(4H, m), 1.42(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.2, 169.1, 154.9, 144.5, 129.6, 127.9, 126.7, 79.7, 66.8, 59.0, 52.2, 51.3, 46.8, 34.5, 29.0, 28.3, 24.6.
化合物62
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.47(1H, d), 4.45(1H, dd), 4.33(1H, dd), 4.09(1H, dd), 3.81-3.50(3H, m), 3.69(3H, s), 2.25-2.17(1H, m), 2.07-1.90(3H, m), 1.40(9H, s), 1.13(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.8, 170.9, 156.2, 79.9, 67.4, 59.3, 55.2, 54.0, 52.7, 52.2, 47.2, 38.5, 30.6, 29.6, 24.8, 18.4.
化合物63
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.29(1H, d), 4.59(1H, dd), 4.48(1H, dd), 3.72-3.62(2H, m), 3.65(3H, s), 2.54(2H, t), 2.19-2.14(1H, m), 2.06(3H, s), 2.02-1.88(4H, m), 1.85-1.77(1H, m), 1.36(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.2, 170.7, 155.4, 79.6, 58.7, 53.4, 50.8, 46.9, 38.5, 32.4, 31.1, 29.7, 28.9, 24.8, 22.1, 15.5.
化合物64
白色固体; 1H NMR(CDCl3, 400MHz) δ 5.56(1H, d), 4.59-4.54(2H, m), 3.87-3.84(1H, m), 3.82-3.76(1H, m), 3.72(3H, s), 3.70-3.63(2H, m), 3.35(1H, s), 2.25-2.17(1H, m), 2.03-1.92(3H, m), 1.40(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.9, 170.2, 155.6, 80.0, 63.9, 58.9, 53.3, 52.6, 47.2, 31.0, 28.8, 28.3, 24.8, 22.1.
化合物65
粘性液体; 1H NMR(CDCl3, 400MHz) δ 7.28-7.17(5H, m), 5.28(1H, d), 4.64(1H, dd), 4.47(1H, dd), 3.70(3H, s), 3.61-3.51(2H, m), 3.18-3.12(1H, m), 3.08(1H, dd), 2.90(1H, dd), 2.15-2.07(1H, m), 1.94-1.83(3H, m), 1.37(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.5, 170.8, 155.3, 136.5, 129.9, 128.5, 126.9, 79.8, 60.6, 59.1, 53.4, 52.4, 47.0, 39.4, 29.2, 28.5, 25.0.
化合物66
粘性液体; 1H NMR(CDCl3, 400MHz) δ 4.56(1H, dd), 4.47(1H, dd), 3.67(3H, s), 3.61-3.32(4H, m), 2.20-1.72(8H, m), 1.41(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.5, 170.8, 156.0, 79.8, 67.4, 58.8, 55.8, 52.4, 47.2, 38.5, 28.8, 28.2, 24.8, 18.6.
化合物67
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.54(1H, d), 4.48(1H, dd), 4.35(1H, dd), 4.11-4.04(1H, m), 3.69(3H, s), 3.74-3.59(2H, m), 3.57-3.49(1H, m), 2.21-2.13(1H, m), 2.02-1.88(3H, m), 1.37(9H, s), 1.17(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.5, 170.8, 156.0, 79.8, 67.4, 58.8, 55.8, 52.4, 47.2, 38.5, 28.8, 28.2, 24.8, 18.6.
化合物68
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.30(1H, d), 4.54(1H, dd), 4.45(1H, dd), 3.72-3.60(2H, m), 3.63(3H, s), 2.51(2H, t), 2.18-2.12(1H, m), 2.03(3H, s), 1.99-1.85(4H, m), 1.82-1.73(1H, m), 1.33(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.2, 170.7, 155.4, 79.6, 58.6, 52.1, 50.8, 46.9, 38.5, 32.4, 29.7, 28.9, 28.2, 24.8, 24.8, 15.5.
化合物69
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.13(1H, d), 4.51(1H, dd), 4.28(1H, dd), 3.82-3.76(1H, m), 3.69(3H, s), 3.66-3.60(1H, m), 2.22-2.16(1H, m), 2.03-1.91(3H, m), 1.75-1.70(1H, m), 1.61-1.52(1H, m), 1.39(9H, s), 1.14-1.06(1H, m), 0.99(3H, d), 0.89(3H, t); 13C NMR(CDCl3, 100MHz) δ 172.4, 171.4, 155.7, 79.4, 58.8, 56.2, 52.1, 47.1, 37.9, 29.0, 28.3, 24.9, 24.1, 15.2, 11.2.
化合物70
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.33(1H, d), 4.51(1H, dd), 4.45(1H, t), 3.69(3H, s), 3.67-3.63(1H, m), 3.60-3.54(1H, m), 2.21-2.14(1H, m), 2.07-1.88(3H, m), 1.39(9H, s), 1.33(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.4, 171.7, 155.2, 79.5, 58.6, 52.2, 47.7, 46.7, 28.9, 28.3, 24.9, 18.2.
化合物71
粘性液体; 1H NMR(CDCl3, 400MHz) δ 7.60(1H, s), 7.06(2H, d), 6.71(2H, d), 5.31(1H, d), 4.61(1H, dd), 4.49(1H, dd), 3.69(3H, s), 3.62-3.58(1H, m), 3.29-3.24(1H, m), 3.00(1H, dd), 2.82(1H, dd), 2.16-2.10(1H, m), 1.94-1.87(3H, m), 1.36(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.3, 171.0, 155.8, 130.7, 127.0, 115.4, 79.9, 59.1, 53.3, 52.2, 46.9, 38.6, 37.9, 28.9, 28.3, 24.8, 22.2.
化合物72
粘性液体; 1H NMR(CDCl3, 400MHz) δ 6.57(1H, s), 5.95(1H, s), 5.62(1H, d), 4.49-4.42(2H, m), 3.69(1H, m), 3.68(3H, s), 3.03(1H, s), 2.31-2.26(2H, m), 2.22-2.14(1H, m), 2.11-1.78(5H, m), 1.37(9H, s); 13C NMR(CDCl3, 100MHz) δ 175.7, 172.8, 170.8, 155.9, 79.9, 58.8, 54.1, 52.4, 51.0, 47.0, 31.1,2 8.9, 28.8, 28.2, 24.8.
化合物73
白色固体; 1H NMR(CDCl3, 400MHz) δ 8.64(1H, s), 7.67(1H, d), 7.33(1H, d), 7.15(1H, d), 7.11(2H, t), 5.35(1H, d), 4.78(1H, dd), 4.50(1H, dd), 3.67(3H, s), 3.55-3.49(1H, m), 3.27-3.09(3H, m), 2.14-2.06(1H, m), 1.91-1.77(3H, m), 1.38(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.6, 171.2, 155.4, 136.1, 127.8, 123.8, 121.7, 119.3, 118.5, 111.2, 109.7, 79.6, 58.8, 58.7, 52.4, 52.1, 46.8, 38.6, 29.0, 28.5, 28.3, 24.8.
化合物74
白色固体; 1H NMR(CDCl3, 400MHz) δ 7.43(6H, d), 7.28(6H, t), 7.21(3H, t), 5.07(1H, d), 4.43(1H, dd), 4.32(1H, dd), 3.61(3H, s), 3.48-3.42(1H, m), 3.12-3.06(1H, m), 2.51(1H, d), 2.15-2.05(1H, m), 1.95-1.75(3H, m), 1.56-1.48(1H, m), 1.40(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.0, 169.5, 155.2, 144.5, 129.7, 127.9, 126.7, 79.8, 66.9, 59.1, 52.1, 51.6, 46.6, 34.1, 28.9, 28.3, 24.7.
化合物75
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.13(1H, d), 4.49(1H, dd), 4.44(1H, t), 3.76-3.70(1H, m), 3.66(3H, s), 3.58-3.53(1H, m), 2.21-2.08(1H, m), 2.05-1.89(3H, m), 1.75-1.69(1H, m), 1.46(2H, t), 1.37(9H, s), 0.95(3H, d), 0.91(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.4, 171.8, 155.7, 79.4, 58.6, 52.1, 50.3, 46.7, 41.8, 28.9, 28.3, 24.8, 24.5, 23.3, 21.7.
化合物76
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.19(1H, d), 4.48(1H, dd), 4.24(1H, dd), 3.76-3.70(1H, m), 3.66(3H, s), 3.63-3.57(1H, m), 2.21-2.13(1H, m), 2.02-1.88(4H, m), 1.37(9H, s), 0.98(3H, d), 0.89(3H, d); 13C NMR(CDCl3, 100MHz) δ 172.4, 171.1, 155.8, 79.3, 58.7, 56.8, 52.0, 47.0, 31.2, 28.9, 28.3, 24.9, 19.2, 17.3.
化合物77
白色固体; 1H NMR(400MHz, CD3OD) δ 7.20-7.42(15H, m), 4.35(1H, dd, J=8.4, 4.0Hz), 4.10(1H, dd, J=9.2, 5.2Hz), 3.60(3H, s), 3.31(1H, m), 3.00(1H, m), 2.48(1H, m), 2.56(1H, m), 2.15(1H, m), 1.90(1H, m), 1.88(2H, m), 1.44(9H, br s).
化合物79
粘性液体; 1H-NMR(CD3OD, 400MHz) δ 4.45(1H, dd, J=5.6Hz and 3.2Hz), 4.30(1H, m), 4.13(m, 1H), 3.73(3H, s), 1.70(1H, m), 1.53-1.58(2H, m), 1.48(9H, brs), 1.17(3H, d, J=6.4Hz), 0.96(3H, d, J=6.4Hz), 0.94(3H, d, J=6.4Hz); 13C NMR(CD3OD, 100MHz) δ 174.7, 170.8, 156.4, 79.2, 67.1, 57.6, 53.3, 51.4, 40.5, 27.3, 24.5, 22.0, 20.5, 18.8.
化合物80
白色固体; 1H NMR(CD3OD, 400MHz) δ 4.38(1H, q, J=6.8Hz), 4.30(1H, m), 4.14(1H, q, J=7.6Hz), 3.92(1H, d, J=6.8Hz), 1.75(1H, m), 1.53(1H, m), 1.43(9H, brs), 1.38(3H, d, J=6.8Hz), 1.25(3H, t, J=7.2Hz), 1.15(1H, m), 0.95(3H, d, J=6.8Hz), 0.90(3H, t, J=7.2Hz) ; 13C NMR(CD3OD, 100MHz) δ 172.8, 172.5, 156.4, 79.1, 60.8, 58.8, 48.2, 37.1, 27.3, 24.3, 16.0, 14.4, 13.0, 10.0.
化合物81
白色結晶性固体; 1H NMR(CD3OD, 400MHz) δ 4.17(1H, t, J=4.4Hz), 3.95(2H, dd, J=17.2, 4.4Hz), 3.75(2H, d, J=5.2Hz), 3.71(3H, s), 1.45(9H, brs) ; 13C NMR(CD3OD, 100MHz) δ 172.3, 170.3, 156.3, 79.4, 61.9, 56.5, 51.3, 40.5, 27.3.
化合物82
粘性液体; 1H NMR(CD3OD, 400MHz) δ 4.41(1H, q, J=6.8Hz), 4.16(2H, q, J=7.6Hz), 3.77(2H, dd, J=17.6, 4.8Hz), 1.44(9H, brs), 1.37(3H, d, J=7.2Hz), 1.25(3H, t, J=6.8Hz) ; 13C NMR(CD3OD, 100MHz) δ 172.7, 170.8, 156.9, 79.2, 60.9, 48.2, 42.9, 27.3, 16.2, 13.0.
化合物83
白色結晶; 1H-NMR(CD3OD, 400MHz) δ 7.18-7.28(5H, m), 4.64(1H, t, J=6.4Hz), 4.12(2H, q, J=6.8Hz), 4.04(1H, m), 3.15(1H, dd, J=14.4, 8.0Hz), 3.0(1H, dd, J=13.6, 7.6Hz), 1.62(1H, m), 1.42(9H, brs), 1.38-1.36(2H, m), 1.88(3H, t, J=7.6Hz), 0.92(3H, t, J=6.4Hz), 0.90(3H, t, J=6.4Hz) ; 13C NMR(CD3OD, 100MHz) δ 174.0, 171.3.8, 156.2, 136.5, 128.9, 128.0, 126.4, 79.1, 60.9, 53.6, 53.0, 40.8, 37.0, 27.3, 24.4, 21.9, 20.6,13.0.
化合物84
白色固体; 1H NMR(CD3OD, 400MHz) δ 7.61(1H, d, J=7.6Hz), 7.35(1H, d, J=7.6Hz), 7.33(1H, d), 7.16(1H, s), 7.11(2H, t, J=7.2Hz), 4.50(1H, t, J=7.6Hz), 4.41(1H, dd, J= 8.0, 3.2Hz), 3.68(3H, s), 3.15-3.20(1H, m), 2.99-3.10(3H, m), 2.19-2.16(1H, m), 1.90-1.83(3H, m), 1.37(9H, s); 13C NMR(CD3OD, 100MHz) δ 172.6, 172.1, 156.2, 136.5, 127.4, 123.7, 121.2, 120.9, 118.5, 110.9, 108.9, 79.1, 59.1, 58.8, 52.8, 51.7, 45.9, 29.6, 28.5, 27.2, 24.3.
化合物85
粘性液体; 1H NMR(CD3OD, 400MHz) δ 4.46(1H, dd, J=8.4, 5.2Hz), 4.20(1H, d, J=8.4Hz), 3.90(1H, m), 3.67(1H, m), 3.69(3H, s), 3.66-3.60(1H, m), 2.27-2.22(1H, m), 2.06-1.92(3H, m), 1.78-1.73(1H, m), 1.63-1.59(1H, m), 1.42(9H, brs), 1.12-1.1.07(1H, m), 0.99(3H, d, J=7.2Hz), 0.89(3H, t, J=6.8Hz); 13C NMR(CDCl3, 100MHz) δ 172.5, 172.1, 156.5, 79.0, 59.0, 56.3, 51.1, 47.1, 36.7, 28.7, 27.3, 24.5, 24.2, 14.0, 9.8.
化合物86
粘性液体; 1H NMR(CD3OD, 400MHz) δ 4.46(1H, dd, J=4.8, 8.8Hz), 4.37(1H, q, J=6.8Hz), 3.77(1H, m), 3.69(3H, s), 3.65-3.62(1H, m), 3.60-3.54(1H, m), 2.30-2.23(1H, m), 2.07-1.93(3H, m), 1.42(9H, s), 1.28(3H, d, J=7.6Hz); 13C NMR(CDCl3, 100MHz) δ 172.7, 172.6, 156.2, 79.0, 58.9, 51.3, 47.7, 46.6, 28.5, 27.3, 24.5, 15.7.
化合物87
粘性液体; 1H NMR(CD3OD, 400MHz) δ 4.36(1H, d, J=6.0Hz), 3.73(2H, brs), 3.71(3H, s), 2.18-2.10(1H, m), 1.44(9H, s), 0.94(3H, d, J=6.8Hz), 0.93(3H, d, J=6.4Hz); 13C NMR(CD3OD, 100MHz) δ 173.5, 172.6, 159.2, 80.8, 59.0, 52.6, 44.5, 32.1, 28.8, 19.5, 18.4.
化合物88
粘性液体; 1H NMR(CD3OD, 400MHz) δ 4.36(1H, dd, J=5.6, 2.8Hz), 3.75(2H, brs), 3.72(3H, s), 2.20-2.12(1H, m), 0.96(3H, d, J=4.4Hz), 0.94(3H, d, J=5.2Hz); 13C NMR(CD3OD, 100MHz) δ 171.8, 166.1, 57.8, 51.1, 39.9, 30.4, 17.9 16.8.
化合物90
白色固体; mp 86-88℃; [α]D -13.6(c 1.0, CH3OH); 1H NMR(CD3OD) δ 7.27(2H, m), 7.20(1H, m), 7.18(2H, m), 4.66(1H, dd, J=8.0, 5.6Hz), 4.45(1H, dd, J=7.6, 6.0Hz), 3.67(3H, s), 3.66(3H, s), 3.13(1H, dd, J=14.0, 5.6Hz), 3.02(1H, dd, J=14.0, 8.0Hz), 2.73(1H, dd, J=16.4, 6.0Hz), 2.59(1H, dd, J=16.4, 7.6Hz), 1.42(9H, s); 13C NMR(CD3OD) δ 171.8, 171.6, 171.1, 156.1, 136.4, 128.9, 128.1, 126.5, 79.5, 53.7, 51.3, 51.0, 48.2, 36.9, 35.8, 27.2.
化合物91
淡黄色粘性液体; [α]D -3.73(c 0.54, CH3OH); 1H NMR(CD3OD) δ 8.24(1H, s), 7.29(2H, m), 7.23(1H, m), 7.20(2H, m), 4.71(1H, dd, J=8.4, 5.6Hz), 4.13(1H, dd, J=8.8, 4.0Hz), 3.74(3H, s), 3.70(3H, s), 3.20(1H, dd, J=14.0, 5.6Hz), 3.02(1H, dd, J=14.0, 8.8Hz), 2.96(1H, dd, J=14.0, 4.0Hz), 2.82(1H, dd, J=17.6, 8.8Hz)ppm; 13C NMR(CD3OD) δ 173.1, 171.8, 169.9, 166.8, 138.0, 130.3, 129.8, 128.2, 55.7, 53.1, 53.0, 51.0, 38.2, 36.6.
化合物92
白色固体; mp 88-91℃; [α]D -11.8(c 1.0, CH3OH); 1H NMR(CD3OD) δ 7.27(2H, m), 7.20(1H, m), 7.18(2H, m), 5.92(1H, ddt, J=17.2, 10.8, 6.0Hz), 5.30(1H, dq, J=17.2, 1.2Hz), 5.20(1H, dd, J=10.8, 1.2Hz), 4.66(1H, dd, J=7.6, 5.2Hz), 4.57(2H, brd, J=6.0Hz), 4.47(1H, dd, J=8.0, 5.2Hz), 3.67(3H, s), 3.13(1H, dd, J=13.2, 5.2Hz), 3.03(1H, dd, J=13.2, 7.6Hz), 2.77(1H, dd, J=16.4, 5.2Hz), 2.61(1H, dd, J=16.4, 8.0Hz), 1.42(9H, s)ppm; 13C NMR(CD3OD) δ 171.8, 171.6, 170.3, 156.1, 136.4, 132.1, 128.9, 128.1, 126.5, 117.0, 79.5, 65.1, 53.7, 51.3, 51.0, 36.9, 35.8, 27.3.
化合物93
粘性液体; [α]D -4.063(c 0.58, CH3OH); 1H NMR(CD3OD) δ 8.24(1H, s), 7.29(2H, m), 7.22(1H, m), 7.20(2H, m), 5.94(1H, ddt, J=17.2, 10.4, 6.0Hz), 5.34(1H, dq, J=17.2, 1.2Hz), 5.25(1H, dd, J=10.4, 1.2Hz), 4.71(1H, dd, J=8.4, 5.6Hz), 4.65(2H, brd, J=6.0Hz), 4.14(1H, dd, J=8.8, 4.0Hz), 3.70(3H, s), 3.20(1H, dd, J=14.0, 5.6Hz), 3.02(1H, dd, J=14.0, 8.8Hz), 2.99(1H, dd, J=14.0, 4.0Hz), 2.85(1H, dd, J=18.0, 9.2Hz) ; 13C NMR(CD3OD) δ 173.1, 171.1, 169.8, 166.8, 138.0, 133.3, 130.3, 129.8, 128.2, 119.2, 67.3, 55.7, 53.0, 50.9, 38.2, 36.7.
化合物94
白色固体; mp 55-60℃; [α]D -9.16(c 1.0, CH3OH); 1H NMR(CD3OD) δ 7.34(2H, m), 7.27(2H, m), 7.25(2H, m), 7.21(1H, m), 7.20(1H, m), 7.18(2H, m), 5.11(2H, s), 4.66(1H, dd, J=8.0, 5.6Hz), 4.45(1H, dd, 7.6, 6.0Hz), 3.67(3H, s), 3.13(1H, dd, 14.0, 5.6Hz), 3.02(1H, dd, 14.0, 8.0Hz), 2.73(1H, dd, 16.4, 6.0Hz), 2.59(1H, dd, 16.4, 7.6Hz), 1.42(9H, s); 13C NMR(CD3OD) δ 171.8, 171.6, 170.4, 156.1, 136.4, 135.9, 128.9, 128.1, 128.1, 127.8, 126.5, 126.5, 79.5, 66.2, 53.7, 51.3, 51.0, 36.9, 35.8, 27.2.
化合物95
粘性液体; 1H NMR(CD3OD) δ 8.18(s), 7.36(2H, m), 7.27(4H, m), 7.25(3H, m), 7.20(1H, m), 7.20(2H, m), 5.19(2H, d, J=2.8Hz), 4.70(1H, dd, J=8.8, 5.2Hz), 4.19(1H, dd, J=8.8, 4.0Hz), 3.67(s), 3.19(1H, dd, J=14.4, 5.6Hz), 2.98(1H, dd, J=14.0, 8.8Hz), 2.96(1H, dd, J=18.0, 4.0Hz), 2.90(1H, dd, J=18.0, 8.8Hz); 13C NMR(CD3OD) δ 173.1, 171.6, 169.8, 166.1, 138.0, 137.2, 130.3, 129.8, 129.8, 129.6, 129.6, 128.2, 68.5, 55.7, 53.0, 50.8, 38.1, 36.5.
化合物96
白色固体; 1H NMR(CD3OD) δ 7.32(2H, m), 7.32(1H, m), 7.32(2H, m), 4.73(1H, dd, J=7.6, 5.2Hz), 4.53(1H, dd, J=8.0, 6.4Hz), 3.67(3H, s), 3.65(3H, s), 3.11(1H, dd, J=14.0, 5.2Hz), 3.01(1H, dd, J=14.0, 7.6Hz), 2.74(1H, dd, J=16.4, 6.4Hz), 2.55(1H, dd, J=16.4, 8.0Hz), 1.89(3H, s); 13C-NMR(CD3OD) δ 171.6, 171.2, 171.2, 168.6, 136.4, 128.8, 128.1,127.2, 126.4, 53.8, 51.3, 51.0, 50.1, 36.8, 34.9, 22.5.
化合物97
白色固体; 1H NMR(CD3OD) δ 7.79(2H,dd, J=6.8, 1.6Hz), 7.57(1H, tt, J=7.6, 1.2Hz), 7.47(2H, t, J=6.8, 8.0), 7.12(2H, m), 7.12(1H, m), 7.12(2H, m), 4.99(1H, dd, J=7.6, 5.2Hz), 4.45(1H, dd, J=8.0, 6.4Hz), 3.67(3H, s), 3.66(3H, s), 3.14(1H, dd, J=14.0, 5.2Hz), 3.00(1H, dd, J=14.0, 7.6Hz), 2.94(1H, dd, J=16.4, 6.4Hz), 2.78(1H, dd, J=16.4, 8.0Hz); 13C NMR(CD3OD) δ 171.6, 171.2, 171.2, 168.6, 136.4, 133.4, 131.6, 128.8, 128.1, 128.1, 127.2, 126.4, 53.8, 51.3, 51.0, 50.1, 36.8, 34.9.
化合物98
白色固体; 1H NMR(CD3OD) δ 7.32(5H, m), 5.92(1H, ddt, J=17.2, 10.8, 6.0Hz), 5.30(1H, dq, J=17.2, 1.2Hz), 5.20(1H, dd, J=10.8, 1.2Hz), 4.80(1H, dd, J=7.6, 5.2Hz), 4.66(1H, dd, J=8.0, 6.4Hz), 4.57(2H, brd, J=6.0Hz), 3.67(3H, s), 3.14(1H, dd, J=14.0, 5.2Hz), 3.00(1H, dd, J=14.0, 7.6Hz), 2.83(1H, dd, J=14.0, 5.2Hz), 2.64(1H, dd, J=16.4, 6.4Hz), 1.89(3H, s); 13C NMR(CD3OD) δ 171.6, 171.2, 170.3, 168.6, 136.5, 132.1, 129.0, 128.2, 126.6, 117.1, 65.1, 53.8, 51.5, 49.5, 36.9, 35.4, 21.2.
化合物99
粘性液体; 1H NMR(CD3OD) δ 7.79(2H, dd, J=6.8, 1.6Hz), 7.57(1H, tt, J=7.6, 1.2), 7.47(2H, dd, J=6.8, 8.0), 7.11(5H, m), 5.92(1H, ddt, J=17.2, 10.8, 6.0Hz), 5.30(1H, dq, J=17.2, 1.2Hz), 5.20(1H, dd, J=10.8, 1.2Hz), 4.99(1H, dd, J=7.6, 5.2Hz), 4.68(1H, dd, J=8.0, 6.4Hz), 4.58(2H, brd, J=6.0Hz), 3.70(3H, s), 3.14(1H, dd, J=14.0, 5.2Hz), 3.01(1H, dd, J=14.0, 7.6Hz), 2.98(1H, dd, J=14.0, 5.2Hz), 2.81(1H, dd, J=16.4, 6.4Hz); 13C-NMR(CD3OD) δ 171.6, 171.2, 170.4, 168.6, 136.4, 134.0, 133.4, 131.6, 128.8, 128.1, 128.1, 127.2, 126.4, 119.0, 65.1, 53.8, 51.3, 51.0, 36.8, 35.0.
化合物100
白色固体; 1H NMR(CD3OD) δ 7.32(5H, m), 7.21(5H, m), 5.11(2H, s), 4.78(1H, dd, J=7.6, 5.2Hz), 4.63(1H, dd, J=8.0, 6.4Hz), 3.67(3H, s), 3.13(1H, dd, J=14.0, 5.2Hz), 3.00(1H, dd, J=14.0, 7.6Hz), 2.84(1H, dd, J=14.0, 5.2Hz), 2.65(1H, dd, J=16.4, 6.4Hz), 1.89(3H, s); 13C NMR(CD3OD) δ 171.8, 171.6, 171.2, 170.2, 168.6, 136.5, 135.9, 128.9, 128.1, 128.1, 127.9, 127.8, 126.5, 66.1, 53.8, 51.3, 49.6, 36.8, 35.4, 21.0.
化合物101
白色固体; 1H NMR(CD3OD) δ 7.79(2H, dd, J=6.8, 1.6Hz), 7.57(1H, tt, J=7.6, 1.2Hz), 7.47(2H, dd, J=6.8, 8.0Hz), 7.34(2H, m), 7.25(4H, m), 7.20(1H, m), 7.12(5H, m), 5.13(2H, s), 4.99(1H, dd, J=7.6, 5.2Hz), 4.45(dd, J=8.0, 6.4Hz), 3.69(s), 3.14(dd, J=14.0, 5.2Hz), 3.00(dd, J=14.0, 5.2Hz), 2.94(dd, J=16.4, 6.4Hz), 2.78(dd, J=6.4, 8.0Hz); 13C NMR(CD3OD) δ 171.6, 171.2, 170.5, 168.6, 136.3, 135.9, 133.4, 131.6, 128.8, 128.1, 128.1, 128.1, 127.9, 127.8, 127.2, 126.4, 66.3, 53.8, 51.3, 50.1, 36.8, 35.2.
化合物102
白色固体; 1H NMR(CD3OD) δ 7.15(3H, m), 7.04(2H, m), 4.65(1H, dd, J=7.6, 5.2Hz), 3.79(1H, dd, J=8.0, 6.4Hz), 3.61(3H, s), 3.11(1H, dd, J=14.0, 5.2Hz), 3.01(1H, dd, J=14.0, 7.6Hz), 2.74(1H, dd, J=16.4, 6.4Hz), 2.55(1H, dd, J=16.4, 8.0Hz), 1.89(3H, s); 13C-NMR(CD3OD) δ 173.1, 171.6, 171.1, 170.7, 135.8, 129.1, 128.4, 126.9, 53.5, 52.2, 49.1, 37.4, 35.3, 22.4.
化合物103
白色固体; 溶融点180-190℃(dec); 1H NMR(CDCl3, 400MHz) δ 7.23(1H, brt), 6.65(1H, d, J=2.2Hz), 4.39(1H, t, J=8.8Hz), 4.08(1H, dd, J=18, 6.0Hz) 3.91(1H, dd, J=18, 6.0Hz), 3.72(3H, s), 2.06(1H, m), 2.0(3H, s), 0.96(3H, d, J=7.6Hz), 0.94(3H, d, J=7.6Hz)ppm; 13C NMR(100MHz, CDCl3) δ172.2, 170.6, 170.2, 58.5, 52.5, 41.3, 31.3, 23.2, 19.3, 18.5ppm.
化合物104
白色固体; 1H NMR(CDCl3, 400MHz) δ 7.17(1H, brt), 6.55(1H, d, J=8.4Hz), 4.56(1H, m), 4.03(1H, dd, J=18.4, 6.0Hz) 3.93(1H, dd, J=18.0, 5.2Hz), 3.72(3H, s), 1.97(3H, s), 1.66(2H, m), 1.54(1H, m), 0.92(3H, d, J=7.6Hz), 0.90(3H, d, J=7.6Hz)ppm; 13C NMR(100MHz, CDCl3) δ172.8, 170.5, 170.1, 52.3, 51.5, 41.1, 41.0, 24.7, 23.0, 22.8, 22.2ppm.
化合物105
白色固体; 1H NMR(CDCl3, 400MHz) δ 7.57(1H, brt), 4.60(1H, dd, J=7.2Hz), 3.97(2H, d, J=6.0Hz), 3.70(3H, s), 3.55(1H, m), 3.41(1H, m), 2.43 〜 2.38(1H. m), 2.10(3H, s), 2.01 〜 1.93(2H, m), 1.90 〜 1.80(1H, m)ppm; 13C NMR(100MHz, CDCl3) δ171.5, 171.1, 170.1, 59.3, 52.2, 48.2, 41.2, 27.3, 24.9, 22.5ppm.
化合物106
粘性液体; 1H NMR(CDCl3, 400MHz) δ 5.39(1H, s), 4.50(1H, dd), 3.94(1H, dd), 3.69(3H, s), 3.59-3.55(1H, m), 3.46-3.40(1H, m), 2.21-2.14(1H, m), 2.10-1.94(4H, m), 1.40(9H, s); 13C NMR(CDCl3, 100MHz) δ 172.8, 167.7, 156.2, 80.0, 58.8, 52.7, 46.2, 43.4, 29.4, 28.7, 25.0.
化合物107
粘性液体; 1H NMR(CD3OD, 400MHz) δ 7.52(1H, d, J=7.6Hz), 7.33(1H, d, J=7.6Hz), 7.10(1H, d), 7.08(1H, s), 7.01(2H, t, J=7.2Hz), 4.80(1H, t, J=7.6Hz), 4.20(1H, dd, J=8.0, 3.2Hz), 3.68(3H, s), 3.39-3.26(1H, m), 3.22-3.17(3H, m), 2.38(H, m), 2.03(3H, m); 13C NMR(CD3OD, 100MHz) δ 173.6, 169.9, 138.2, 128.7, 124.7, 122.7, 120.0, 119.7, 112.6, 110.6, 61.0, 60.9, 55.4, 53.0, 47.6, 31.2, 28.5, 25.0.
化合物108
粘性液体; 1H NMR(CD3OD, 400MHz) δ 4.47(1H, q), 3.70(3H, s), 3.68(1H, d), 2.21(1H, m), 1.42(3H, s), 1.09(6H, d); 13C NMR(CD3OD, 100MHz) δ 174.2, 169,5, 59.7, 52.9, 49.7, 31.7, 18.8, 18.0, 17.3.
化合物109
白色固体; 1H NMR(CD3OD, 400MHz) δ 4.90(1H, q, J=6.8Hz), 4.84(1H, m), 4.47(1H, q, J=7.6Hz), 3.70(1H, d, J=6.8Hz), 1.94(1H, m), 1.61(1H, m), 1.42(3H, d, J=6.8Hz), 1.22(1H, m), 1.07(3H, d, J=6.8Hz), 0.99(3H, t, J=7.2Hz); 13C NMR(CD3OD, 100MHz) δ 174.7, 169.5, 59.1, 52.9, 49.7, 38.3, 25.4, 17.3, 15.1, 11.8.
本発明のジペプチド誘導体をトウガラシ幼苗に処理した時の病抵抗性の発現を証明するために、PR−1、β−1,3−グルカナーゼ、キチナーゼ、PR4、ペルオキシダーゼ、PR10プライマー及びトウガラシ幼苗を用いた。トウガラシ幼苗を温室で4週間育てて化合物を濃度別に散布し、3日後または1週後に疫病菌(Phytophthora capcisi)と植物軟腐病菌(Pectobacterium carotovorum)をそれぞれ接種した。
PR−1α病抵抗性プロモーターにより誘導されたGUS遺伝子が結合されたタバコ(Xanth−nc)を3週間育苗した後、第2葉に化合物74の希釈液を100uLずつ注射器で注入した。3日後に周辺の葉を内径5mmの大きさのコルクボーラーで採取した後、試料を1.5mLエッペンドルフチューブに入れ、GUS抽出緩衝液20uLを加えて磨砕した後、8000Gで3分間遠心分離して上澄液を取った。同量の2mMのMUG(4−メチルウンベリフェリル−B−グルクロニド)溶液を入れ、37℃で1時間反応させた後、960uLの停止緩衝液(0.2M、Na2CO3溶液)を添加して1mLにした後、TKO100蛍光計(Hoefoer Scientific Instruments USA)で蛍光を測定した。この時、MU(4−メチルウンベリフェロン)を標準試薬として蛍光量を補正し、GUS活性はMU−mM/試料−10mg/時間にした。その結果は下記表2と図2に示した。
本発明の化合物を各種植物に処理した後、下記方法により植物病発病の抑制効果を測定した。
キュウリの種子に有効成分の化合物61と化合物74を100ppmの濃度で2時間沈積した後に播種し、3週後に炭疽病菌(Colletotrichum orbiculare)の胞子を105spore/mLで散布し、7日後に病発生率を調べた。その結果は図4の写真に示した。
実施例3と同様な方法によりトウガラシを育てた後、化合物85を葉にスプレーして1週後、Phytophthora capsici遊走子懸濁液を灌注して接種した。7日間観察しながら、葉と根での病斑形成程度を調べた。対照群に比べて、化合物85を処理したトウガラシでは根と葉での疫病の発病が顕著に抑制された。化合物85の疫病発病の抑制効果の実験結果を図10に示した。
植物(トウガラシ、ジャガイモ、トマト、タバコ、キュウリ、ハクサイ)の葉に有効成分物質(化合物5〜8、14、15)を灌注処理し、7日後に草長を測定し、植物病を接種し、3〜5日後に植物葉の大きさを測定して対照群と比較し、相対的な生長程度を測定した。下記表8はキュウリ葉での生長促進効能を示すものである。
本発明による化合物の植物免疫増強効果を調べるために、植物を人為的に冷害をもたらす温度で放置した後の生長を調べた。植物を6週間生長させた後、灌注したり葉にスプレーして1週間生長させた。次いで、植物を2℃の生長室に1日間露出させてから、再び室温で3日間生長させた後、植物の生長程度を観察して植物の冷害程度を判定した。化合物95を灌注処理した時に植物に冷害が全然生じず、葉にスプレーした時、化合物90、91、93、95を処理した時も植物に冷害が生じなかった。前記試験結果は、化合物を処理した時に植物が病抵抗性を有すると共に、冷害のような物理的な有害環境でも生長を維持できる免疫増強効果が誘発されるという証拠である。このような試験結果を図11と図12の写真に示した。
本製剤例では、本発明に用いる前記ジペプチド化合物を活性成分として含む農業用作物保護剤を適用目的に適するように製剤化する代表例である。製剤化に用いられた各使用成分の組成は、下記の通りである。
本発明に用いる前記ジペプチド化合物10g、NK250L(界面活性剤)10g、ホワイトカーボン10g、パイロフィライト(Pyrophylite;増量剤)70gを粉砕混合して水和剤を製造した。
本発明に用いる前記ジペプチド化合物10g、DDY2000(界面活性剤)10g、キシレン80gを混合して油剤を製造した。
本発明に用いる前記ジペプチド化合物10g、HY1910(界面活性剤)10g、プロピレングリコール5g、キサンタンガム0.2g、KM−73(消泡剤)0.15g、バイオサイド(Biocide)−LS(防腐剤)0.2g、KNP(増粘剤)0.1g、水(増量剤)74.35gをボールミル(Ball mill)で粉砕混合して液状水和剤を製造した。
本発明に用いる前記ジペプチド化合物5g、パラフィンオイル7.5g、アルキルスルホコハク酸ナトリウム(界面活性剤)2g、ホワイトカーボン3g、キサンタンガム1.2g、ポリアクリル酸ナトリウム0.8g、塩化カリウム80.5gを混合して水平式押出成形機で粒化、乾燥して水面浮上性粒剤を製造した。
本発明に用いる前記ジペプチド化合物5g、HY1910(界面活性剤)2.5g、NK250L(界面活性剤)0.2g、ソーダ灰0.5g、デキストリン2.0g、ベントナイト25g、滑石(Talc)64.8gを水と混合し、水平式押出成形機で粒化、乾燥して粒剤を製造した。
前記製剤例1ないし5において、活性成分として使われる本発明に用いる前記ジペプチド化合物重量の20重量%内で商業的に用いられている通常の殺菌剤、殺虫剤、除草剤から選択された単独または混合物を代替使用して混合剤を製造した。
Claims (8)
- 植物の発病を予防し、成長を促進させる農業用作物保護剤を製造するために、ジペプチド誘導体または農薬学的に許容可能なその塩から選択された化合物を活性成分として用いる農業用作物保護剤の製造方法であって、
前記ジペプチド誘導体は、
メチル2−(2−アミノ−4−メチルペンタンアミド)アセテート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−メチルブタンアミド)アセテート;
メチル2−(2−アミノ−3−メチルブタンアミド)アセテート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−ヒドロキシブタンアミド)−4−メチルペンタノエート;
メチル2−(2−アミノ−3−ヒドロキシブタンアミド)−4−メチルペンタノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−エタンアミド)プロパノエート;
メチル2−(2−((t−ブトキシカルボニル)アミノ)−3−((4−ヒドロキシフェニル)プロパンアミド)プロパノエート;
エチル2−(2−((t−ブトキシカルボニル)アミノ)−3−メチルペンタンアミド)−プロパノエート;
3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパン酸;
メチル3−(1−メトキシカルボニル−2−フェニルエチルカルバモイル)−3−(t−ブトキシカルボニルアミノ)プロパノエート;
メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ブトキシカルボニルアミノ)プロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−アミノプロパノエート;
メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパノエート;
メチル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ベンゾイルアミノ)プロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパノエート;
ベンジル3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−ベンゾルアミノ)プロパノエート;
3−(1−(メトキシカルボニル)−2−フェニルエチルカルバモイル)−3−(N−アセチルアミノ)プロパン酸;
メチル2−((2−アセチルアミノ)−3−メチルブタンアミド)アセテート;
メチル2−((2−アセチルアミノ)−4−メチルペンタンアミド)アセテート;
メチル2−(2−アミノ−3−メチルペンタンアミド)プロパノエート、又は農薬学的に許容可能なそれらの塩から選択された化合物を活性成分として含むことを特徴とする農業用作物保護剤の製造方法。 - 前記ジペプチド誘導体に一つ以上のキラル炭素が存在する場合には、前記活性成分は前記ジペプチド誘導体のラセミ混合物であり、又は前記ジペプチド誘導体の異性体化合物を含むことを特徴とする請求項1に記載の製造方法。
- 請求項1に記載の製造方法であって、前記農業用作物保護剤は、水和剤、懸濁剤、乳濁剤、液剤、分散性液剤、顆粒水和剤、粒剤、粉剤、液状水和剤、顆粒水和剤、水面浮上性粒剤、または錠剤に構成されたグループから選択された種類から形成された製造方法。
- 前記農業用作物保護剤は、植物病防除効能、植物生長促進効能、植物免疫増強効能、またはこれらの効能を同時に有することを特徴とする請求項1に記載の製造方法。
- 前記農業用作物保護剤が前記植物病防除効能を有する植物病は、軟腐病、立枯病、疫病、つる割病、斑点病、またはモザイク病であることを特徴とする請求項4に記載の製造方法。
- 前記植物は、双子葉植物であることを特徴とする請求項4に記載の製造方法。
- 前記双子葉植物は、ジャガイモ、トウガラシ、ピーマン、トマト、キュウリ、タバコ、スイカ、マクワウリ、ハクサイ、チシャ、大根、キャベツ、アブラナ、ピーナッツ、サラリー、ニンジン、トウキ、エゴマ、イチゴ、リンゴの木、梨の木、桃の木及び柿の木からなる群から選択されることを特徴とする請求項6に記載の製造方法。
- 前記植物は、ネギ、ニンニク、ショウガ、タマネギ、稲、麦、トウモロコシ、モロコシ、であることを特徴とする請求項4に記載の製造方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2012-0040279 | 2012-04-18 | ||
KR20120040279 | 2012-04-18 | ||
PCT/KR2013/003303 WO2013157871A1 (ko) | 2012-04-18 | 2013-04-18 | 다이펩타이드 유도체를 활성 성분으로 함유하는 농업용 작물 보호제 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015514753A JP2015514753A (ja) | 2015-05-21 |
JP6219928B2 true JP6219928B2 (ja) | 2017-10-25 |
Family
ID=49383749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015506901A Active JP6219928B2 (ja) | 2012-04-18 | 2013-04-18 | 農業用作物保護剤の製造方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20150119251A1 (ja) |
JP (1) | JP6219928B2 (ja) |
KR (1) | KR101352566B1 (ja) |
CN (1) | CN104363756B (ja) |
WO (1) | WO2013157871A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101590255B1 (ko) | 2014-06-26 | 2016-01-29 | 주식회사 나프로바이오텍 | 미생물 Bacillus vallismortis BS07M 균주 발효액으로부터 제조된 고리형 다이펩타이드의 제조방법 |
KR101441986B1 (ko) | 2014-07-11 | 2014-09-24 | 주식회사 포이엔 | 농업용 약제 조성물 및 이의 제조방법 |
JP7059119B2 (ja) * | 2017-06-26 | 2022-04-25 | 三洋化成工業株式会社 | 植物成長促進剤 |
KR102493517B1 (ko) * | 2022-08-29 | 2023-01-31 | 김재현 | 냉해방지용 친환경 액상조성물 제조방법 및 냉해방지용 친환경 액상조성물 |
KR102629781B1 (ko) * | 2023-06-21 | 2024-01-25 | 임병성 | 냉해 및 동해 예방용 친환경 식물 영양제 제조방법 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4169141A (en) * | 1978-01-30 | 1979-09-25 | Shering Corporation | 1-Peptidyl derivatives of di-O-aminoglycosyl-1,3-diaminocyclitol antibacterial agents |
US4752602A (en) * | 1985-09-09 | 1988-06-21 | Board Of Regents, The University Of Texas System | Dipeptide alkyl esters and their uses |
JPS62240603A (ja) * | 1986-04-11 | 1987-10-21 | Teijin Ltd | 植物生長促進剤および植物生長促進法 |
JPS6372607A (ja) * | 1986-09-12 | 1988-04-02 | Teijin Ltd | 抗植物病害組成物および抗植物病害方法 |
IL107719A0 (en) * | 1992-12-21 | 1994-02-27 | Du Pont | Imidazolones their manufacture and their use as herbicides |
CA2144321C (en) * | 1993-08-03 | 1999-07-13 | Nick E. Christians | Preemergence weed control using natural herbicides |
IT1270882B (it) * | 1993-10-05 | 1997-05-13 | Isagro Srl | Oligopeptidi ad attivita' fungicida |
IT1271026B (it) * | 1994-10-21 | 1997-05-26 | Isagro Ricerca Srl | Derivati dell'acido b-amminopropionico ad attivita' fungicida |
US6153591A (en) * | 1998-03-16 | 2000-11-28 | Cytovia, Inc. | Dipeptide caspase inhibitors and the use thereof |
IT1303800B1 (it) * | 1998-11-30 | 2001-02-23 | Isagro Ricerca Srl | Composti dipeptidici aventi elevata attivita' fungicida e loroutilizzo agronomico. |
GB0005703D0 (en) * | 2000-03-09 | 2000-05-03 | Alpharma As | Compounds |
ITMI20040402A1 (it) * | 2004-03-03 | 2004-06-03 | Isagro Spa | Miscele e metodo per l'induzione di resistenza nella pianta |
US8815773B2 (en) * | 2009-07-29 | 2014-08-26 | Upl Limited | Herbicidal combination |
KR101191977B1 (ko) * | 2010-04-28 | 2012-10-17 | 대한민국(관리부서:농촌진흥청장) | 2,5-다이케토피페라진 화합물의 제조방법 |
KR101278140B1 (ko) * | 2010-07-15 | 2013-06-27 | 공주대학교 산학협력단 | 2,5-다이케토피페라진 유도체를 활성성분으로 포함하는 농업용 약제 |
-
2013
- 2013-04-18 US US14/395,422 patent/US20150119251A1/en not_active Abandoned
- 2013-04-18 KR KR20130042757A patent/KR101352566B1/ko active IP Right Grant
- 2013-04-18 WO PCT/KR2013/003303 patent/WO2013157871A1/ko active Application Filing
- 2013-04-18 JP JP2015506901A patent/JP6219928B2/ja active Active
- 2013-04-18 CN CN201380028197.3A patent/CN104363756B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
US20150119251A1 (en) | 2015-04-30 |
KR20130117720A (ko) | 2013-10-28 |
CN104363756A (zh) | 2015-02-18 |
CN104363756B (zh) | 2017-10-31 |
KR101352566B1 (ko) | 2014-01-17 |
JP2015514753A (ja) | 2015-05-21 |
WO2013157871A1 (ko) | 2013-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6046617B2 (ja) | 2,5−ジケトピペラジン誘導体を活性成分として含む農業用薬剤 | |
JP6219928B2 (ja) | 農業用作物保護剤の製造方法 | |
FI63567C (fi) | Substituerad furan-2-karbonsyra-anilid med fungicidisk verkan och dess anvaendning | |
EA020376B1 (ru) | Новые фунгицидно активные пиразолкарбоксамиды | |
EA024266B1 (ru) | Кетоенолы, замещенные галоидалкилметиленоксифенилом, и их применение | |
US5830919A (en) | Method to protect plants from fungal infection | |
US11793196B2 (en) | Fusion proteins, recombinant bacteria, and exosporium fragments for pest control and plant health | |
JP2514823B2 (ja) | 病気から植物を保護する方法及び薬剤 | |
US20220169999A1 (en) | Fusion proteins, recombinant bacteria, and exosporium fragements for plant health | |
EA019414B1 (ru) | Новые микробиоциды | |
JPS5939401B2 (ja) | 微生物防除剤とその製法 | |
JP2019085382A (ja) | 植物ウイルス病の予防又は治療剤 | |
CN115160219A (zh) | 含吡啶酰胺类结构的化合物及其制备方法和应用、杀菌剂 | |
JP7078982B2 (ja) | 植物の土壌伝染性病害防除方法 | |
WO2024010005A1 (ja) | 植物の虫害を防止する方法 | |
EP3328201B1 (en) | Application of 7-carboxybenzo[1,2,3]thiadiazole amides as plant stimulants | |
AU595269B2 (en) | Plant growth promotion | |
ES2346195T3 (es) | Nuevos derivados de fenetilamida de acido carboxilico alfa-oxigenados. | |
SU592330A3 (ru) | Средство дл регулировани роста растений | |
KR800000712B1 (ko) | 아닐린 유도체의 제조방법 | |
JP2013082661A (ja) | プラントアクティベーター | |
UA73153C2 (en) | Pyrazolcarboxamide and pyrazolthioamide derivatives as a fungicides | |
JPS6143321B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150115 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20151207 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160405 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160705 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20160905 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160905 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170307 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20170607 Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170607 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170912 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170928 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6219928 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |